{"gene":"PTK2B","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1995,"finding":"RAFTK/PYK2 was identified as a novel cytoplasmic tyrosine kinase (1009 aa) related to FAK, lacking transmembrane regions, myristylation sites, and SH2/SH3 domains, but containing a kinase domain flanked by large N- and C-terminal domains with a proline-rich C-terminal stretch. It is expressed in megakaryocytes and brain, and thrombin stimulation of megakaryocytic CMK cells induced rapid tyrosine phosphorylation of the ~123-kDa RAFTK protein.","method":"cDNA cloning, sequence analysis, immunoprecipitation, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — original characterization using immunoprecipitation and Western blot with functional phosphorylation readout, single lab","pmids":["7499242"],"is_preprint":false},{"year":1996,"finding":"RAFTK/PYK2 has intrinsic tyrosine kinase and autokinase activities. It localizes to focal adhesion-like structures (co-localizing with vinculin) upon fibronectin activation in megakaryocytic CMK cells and transfected COS cells. Its SH2 domains of Src, Fyn, and adaptor Grb2 associate specifically with tyrosine-phosphorylated RAFTK. Fibronectin-induced integrin signaling triggers RAFTK phosphorylation, and dephosphorylation occurs upon cell detachment with re-phosphorylation upon replating on fibronectin.","method":"In vitro kinase assay, immunoprecipitation, confocal microscopy, transfection of COS cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay plus reciprocal Co-IP and direct localization, single lab with multiple orthogonal methods","pmids":["8695788"],"is_preprint":false},{"year":1996,"finding":"Pyk2 is activated by stress signals including TNF-alpha, UV irradiation, and osmotic shock, and overexpression of Pyk2 leads to JNK activation. A dominant-negative Pyk2 mutant interferes with UV- or osmotic shock-induced JNK activation, placing Pyk2 upstream of JNK in stress signaling.","method":"Overexpression, dominant-negative mutant, kinase activity assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis and gain-of-function overexpression with JNK activity readout, published in high-tier journal, single lab","pmids":["8670418"],"is_preprint":false},{"year":1997,"finding":"RAFTK is tyrosine-phosphorylated rapidly (within 10 s) during early platelet activation by thrombin in an integrin glycoprotein IIb-IIIa-independent manner. RAFTK phosphorylation is calcium-dependent, regulated by protein kinase C, requires intact actin cytoskeleton (blocked by cytochalasin D), and occurs independently of platelet aggregation. RAFTK is proteolytically cleaved by calpain in an aggregation-dependent manner.","method":"Platelet activation assays, immunoprecipitation, Western blot, pharmacological inhibitors","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological dissection approaches in primary platelets, single lab","pmids":["9099753"],"is_preprint":false},{"year":1997,"finding":"RAFTK is phosphorylated and its kinase activity increases upon T cell receptor (TCR) activation in human T cells. After TCR stimulation, Fyn and Grb2 associate with phospho-RAFTK via their SH2 domains; RAFTK also co-immunoprecipitates with Lck SH2 domain and with paxillin via its C-terminal proline-rich domain. Cytochalasin D pretreatment reduces RAFTK phosphorylation, implicating cytoskeletal integrity in this process.","method":"Immunoprecipitation, kinase assay, SH2 domain binding, Western blot","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and SH2 domain binding assays, single lab","pmids":["9091579"],"is_preprint":false},{"year":1997,"finding":"RAFTK activation in Kaposi's sarcoma cells by multiple cytokines (bFGF, VEGF, VRP, OSM, IL-6, TNF-alpha) leads to its association with paxillin via the hydrophobic C-terminal domain of the kinase, and downstream JNK activation.","method":"Immunoprecipitation, kinase assay, Western blot","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP identifying paxillin as C-terminal domain binding partner, single lab, single method for domain mapping","pmids":["9120025"],"is_preprint":false},{"year":1998,"finding":"MIP-1β binding to CCR5 activates RAFTK, with subsequent activation of paxillin, JNK/SAPK, and p38 MAPK. A dominant-negative RAFTK kinase mutant markedly attenuates JNK/SAPK activity downstream of CCR5, placing RAFTK as a functional bridge linking CCR5 receptor signaling to the cytoskeleton and nucleus.","method":"Dominant-negative mutant, kinase assay, Western blot","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis with defined downstream readouts, single lab","pmids":["9446638"],"is_preprint":false},{"year":1998,"finding":"m1 muscarinic acetylcholine receptor activation stimulates PYK2 tyrosine kinase activity. Two specific tyrosine residues on PYK2 are phosphorylated upon muscarinic signaling, inducing binding of c-Src and Grb2 to PYK2. PYK2 specifically phosphorylates the C-terminal cytosolic portion of potassium channel Kv1.2 in an m1 receptor-regulated manner. Paxillin associates constitutively with PYK2 independent of muscarinic signaling.","method":"Stable cell lines, kinase assay, site-directed mutagenesis of phosphorylation sites, in vitro phosphorylation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with substrate identification (Kv1.2), mutagenesis of phospho-tyrosines, and binding partner identification (Src, Grb2), multiple orthogonal methods","pmids":["9560226"],"is_preprint":false},{"year":1998,"finding":"In cardiac fibroblasts, angiotensin II activates Pyk2/CAKbeta/RAFTK in a Ca2+/calmodulin-sensitive manner. Overexpression of dominant-negative Pyk2 significantly attenuates Ang II- or calcium ionophore-induced ERK activities and GTP-Ras loading, placing Pyk2 upstream of the Ras/ERK pathway downstream of Ang II.","method":"Dominant-negative overexpression, ERK kinase assay, Ras-GTP loading assay, pharmacological inhibitors","journal":"Hypertension","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis with Ras-GTP and ERK readouts, single lab","pmids":["9774361"],"is_preprint":false},{"year":1999,"finding":"RAFTK/Pyk2 activation is required for dexamethasone-induced apoptosis in multiple myeloma cells. Wild-type RAFTK overexpression induces apoptosis, while kinase-inactive RAFTK blocks dexamethasone-induced apoptosis but not IR- or Fas-mediated apoptosis. IL-6 inhibits both RAFTK activation and dexamethasone-triggered apoptosis.","method":"Transient overexpression, kinase-inactive mutant, apoptosis assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-inactive mutant rescue and gain-of-function in defined apoptosis pathway, single lab","pmids":["10597281"],"is_preprint":false},{"year":2000,"finding":"Pyk2 and FAK associate with EGF receptor-containing adhesion complexes through their C- and N-terminal domains, respectively, during neurite outgrowth. Expression of the C-terminal domain of Pyk2 or FAK blocks neurite outgrowth but not ERK activation. Autophosphorylation of Pyk2/FAK and phosphorylation of paxillin are required for neurite formation.","method":"Overexpression of domain constructs, immunoprecipitation, morphological assay in PC12 and SH-SY5Y cells","journal":"Nature cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-deletion analysis with defined neurite outgrowth phenotype and receptor complex Co-IP, single lab","pmids":["10980697"],"is_preprint":false},{"year":2000,"finding":"RAFTK/Pyk2 tyrosine phosphorylation upon NGF stimulation requires phospholipase Cγ activity and intracellular Ca2+. Paxillin co-immunoprecipitates with RAFTK and its phosphorylation is Ca2+-dependent. By confocal microscopy, RAFTK translocates from cytoplasm to neurite initiation sites at the cell periphery within 5 min, where it co-localizes with paxillin and actin. Potassium depolarization induces RAFTK and paxillin phosphorylation in a Ca2+-dependent manner.","method":"Immunoprecipitation, confocal microscopy, pharmacological inhibitors, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence (neurite initiation) and Co-IP, single lab","pmids":["10764815"],"is_preprint":false},{"year":2000,"finding":"FIP200 (FAK family kinase-interacting protein of 200 kDa) was identified as a Pyk2-interacting protein that binds the kinase domain of Pyk2 and inhibits its kinase activity in vitro. FIP200 inhibits Pyk2 kinase activity isolated from SYF cells (Src/Yes/Fyn deficient) and a Pyk2 mutant lacking the Src binding site, indicating direct inhibition. Activation of Pyk2 by biological stimuli correlates with dissociation of the endogenous FIP200-Pyk2 complex. FIP200 also inhibits Pyk2-induced apoptosis in intact cells.","method":"Yeast two-hybrid screen, in vitro binding assay, Co-immunoprecipitation, in vitro kinase assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase inhibition assay plus Co-IP and cellular functional assays, multiple orthogonal methods, single lab","pmids":["10769033"],"is_preprint":false},{"year":2000,"finding":"Pyk2 inhibits G1-to-S phase transition (whereas FAK promotes it). This differential cell cycle regulation maps to the C-terminal domain of Pyk2 (chimeric PFhy1 with Pyk2 N-term/FAK C-term promotes cell cycle; FPhy2 with FAK N-term/Pyk2 C-term inhibits it). Pyk2 and FPhy2 stimulate JNK activation while inhibiting ERK activation in adhesion, linking these pathway differences to cell cycle outcomes. Pyk2 localizes to cytoplasm (not focal contacts), unlike FAK.","method":"Tetracycline-regulated expression, chimeric constructs, flow cytometry, kinase assays, immunofluorescence","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chimeric domain-swap constructs with cell cycle and signaling readouts, single lab with multiple methods","pmids":["10934044"],"is_preprint":false},{"year":2000,"finding":"CADTK/Pyk2 localizes to the leading edge and ruffling lamellipodia of adherent human monocytes. Introduction of the dominant-negative C-terminal fragment CRNK inhibits CADTK autophosphorylation, reduces cell spreading, inhibits adhesion-induced phosphotyrosine increases and ERK activation, and reduces monocyte motility (from 83% to 26% motile cells). CRNK introduction does not affect phagocytosis or adhesion-induced cytokine gene induction.","method":"Immunocytochemistry, electroporation of dominant-negative construct (GST-CRNK), motility assay, ERK assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative with multiple orthogonal functional readouts (localization, spreading, ERK, motility) and negative controls, single lab","pmids":["11062241"],"is_preprint":false},{"year":2001,"finding":"Nephrocystin forms protein complexes with Pyk2, p130(Cas), and tensin as shown by immunoprecipitation of native nephrocystin. Expression of nephrocystin results in phosphorylation of Pyk2 at tyrosine 402 and activation of downstream ERK1 and ERK2, suggesting nephrocystin recruits Pyk2 to cell-matrix adhesions.","method":"Immunoprecipitation, Western blot with phospho-specific antibody, ERK activation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of endogenous proteins plus functional phosphorylation readout at defined tyrosine residue, single lab","pmids":["11493697"],"is_preprint":false},{"year":2001,"finding":"Pyk2 tyrosine kinase activity is required for pulmonary vascular endothelial cell spreading, migration, morphogenesis, and pulmonary vein/artery angiogenesis ex vivo. Pyk2 kinase activity is required for expression of focal adhesion kinase, p130Crk-associated substrate, and HEF1, linking Pyk2 to focal adhesion formation and cytoskeletal reorganization.","method":"Adenovirus-mediated expression of Pyk2 mutants (kinase-dead), endothelial migration/morphogenesis assays, ex vivo angiogenesis assay, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-dead mutant with multiple functional readouts, single lab","pmids":["11739395"],"is_preprint":false},{"year":2001,"finding":"RAFTK/Pyk2 is co-immunoprecipitated with PI3K upon platelet activation, and thrombin, ADP, and collagen induce phosphorylation of both PI3K and RAFTK. At low thrombin doses, RAFTK phosphorylation and platelet aggregation are PI3K activity-dependent. SHP-2 (protein tyrosine phosphatase-2) associates with RAFTK upon platelet activation in a PI3K-dependent manner.","method":"Immunoprecipitation, kinase assay, pharmacological inhibitors (wortmannin), Western blot","journal":"British journal of haematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of endogenous proteins plus pharmacological epistasis, single lab","pmids":["11472358"],"is_preprint":false},{"year":2002,"finding":"HRG stimulation of T47D breast cancer cells induces RAFTK association with p190 RhoGAP, RasGAP, and ErbB-2. RAFTK mediates Src-dependent tyrosine phosphorylation of p190, and mutation of the Src binding site (Y402) of RAFTK abolishes p190 phosphorylation. ErbB-2 association with RAFTK is indirect and mediated by Src. Wild-type RAFTK expression increases breast cancer cell invasion; kinase mutant RAFTK-R457 and Y402 mutant do not.","method":"Immunoprecipitation, site-directed mutagenesis, invasion assay, Western blot","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of key residue plus Co-IP and functional invasion assay, single lab","pmids":["10713673"],"is_preprint":false},{"year":2002,"finding":"Pyk2 interacts with ARA55 (androgen receptor coregulator) and phosphorylates ARA55 at tyrosine 43, impairing ARA55 coactivator activity and/or sequestering ARA55 to reduce AR transactivation. This indirect modulation of androgen receptor function by Pyk2 was demonstrated by yeast two-hybrid, co-IP, and in vitro phosphorylation.","method":"Yeast two-hybrid, Co-immunoprecipitation, in vitro phosphorylation, transactivation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro phosphorylation with site identification plus Co-IP, single lab","pmids":["11856738"],"is_preprint":false},{"year":2002,"finding":"Pyk2/RAFTK-mediated alpha-synuclein tyrosine phosphorylation at Y125 occurs in response to hyperosmotic stress, with Src-family kinases acting downstream of Pyk2 as the proximal kinases for alpha-synuclein. Dominant-negative Pyk2 reduces osmotic stress-induced alpha-synuclein phosphorylation.","method":"Western blot, dominant-negative Pyk2 construct, phospho-specific detection, site-directed mutagenesis of alpha-synuclein","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis with site-specific phosphorylation readout, single lab","pmids":["12096713"],"is_preprint":false},{"year":2002,"finding":"In neonatal rat cardiomyocytes, adenoviral RAFTK/Pyk2 expression induces apoptosis via concurrent phosphorylation of Src, JNK, and p38, leading to PARP cleavage, caspase-3 activation, and DNA laddering. Mutation of the Y402 Src-binding site reduces DNA laddering. Wild-type or phosphorylation-deficient paxillin (mutated at Y31/Y118) prevents RAFTK-mediated apoptosis and preserves myofibril organization.","method":"Adenoviral expression, site-directed mutagenesis (Y402), caspase assay, PARP cleavage, paxillin rescue","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of key Src-binding site plus multiple downstream apoptosis readouts and paxillin rescue, single lab","pmids":["15322113"],"is_preprint":false},{"year":2003,"finding":"Pyk2 acts as a scaffold for Src-dependent phosphorylation of PDK1 on Tyr9, enabling subsequent Src phosphorylation of PDK1 on Tyr373 and Tyr376 downstream of angiotensin II in vascular smooth muscle cells. Pyk2 and tyrosine-phosphorylated PDK1 co-localize in focal adhesions after Ang II stimulation. A Tyr9 mutant of PDK1 inhibits Ang II-induced paxillin phosphorylation and focal adhesion formation.","method":"Adenoviral expression, site-directed mutagenesis of PDK1 (Y9), confocal co-localization, immunoprecipitation, Western blot","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with defined phospho-site, co-localization, and functional adhesion readout, single lab","pmids":["14585963"],"is_preprint":false},{"year":2004,"finding":"RAFTK/Pyk2 autophosphorylation occurs via a trans-acting (intermolecular) mechanism, not a cis-acting mechanism. Kinase-mutated RAFTK inhibits wild-type RAFTK autophosphorylation in a dose-dependent trans manner. Trans-autophosphorylation occurs only at Tyr402, and this is Src kinase activity-independent. Src significantly enhances RAFTK-mediated paxillin phosphorylation downstream of Tyr402. RAFTK self-associates, and this association is not dependent on a single domain.","method":"Dual-tag RAFTK constructs, immunoprecipitation, affinity chromatography, in vitro kinase assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with dual-tag co-expression, affinity chromatography, and Src independence established by SYF cells, multiple orthogonal methods, single lab","pmids":["15166227"],"is_preprint":false},{"year":2004,"finding":"VEGF-induced p38 MAPK activation in endothelial cells is dependent on RAFTK/Pyk2 (dominant-negative Pyk2 reduces p38 activation) and is calcium-dependent (EGTA blocks it). Src family kinase activity is also required upstream of p38, and both Src and RAFTK/Pyk2 are essential for VEGF-induced endothelial cell migration. This pathway is distinct from PLC-dependent ERK activation.","method":"Dominant-negative Pyk2 expression, pharmacological inhibitors, kinase assay, migration assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative epistasis with defined pathway bifurcation, single lab","pmids":["14676843"],"is_preprint":false},{"year":2005,"finding":"Pyk2 autophosphorylation is necessary but not sufficient for glioma cell migration. The N-terminal domain of Pyk2 is required to stimulate migration (N-terminal deletion abolishes migration stimulation; autonomous N-terminal domain inhibits migration). Substitution of the Pyk2 C-terminal domain with the FAK C-terminal domain retains Pyk2-mediated migration stimulation, while substitution of the N-terminal domain with FAK N-terminus inhibits migration. siRNA silencing of Pyk2 inhibits glioma migration; re-expression of Pyk2 (but not FAK) restores it.","method":"Domain-swap chimeric constructs, siRNA knockdown, cell migration assay, RNA interference rescue","journal":"Neoplasia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-mapping with chimeras plus siRNA knockdown/rescue, single lab","pmids":["15967096"],"is_preprint":false},{"year":2005,"finding":"Loss of VE-cadherin function triggers Rac1 activation and ROS production, which activate Pyk2. Active Pyk2 is recruited to cell-cell junctions and phosphorylates VE-cadherin-associated beta-catenin on tyrosine. Expression of dominant-negative CRNK (N-terminal deletion mutant) abolishes the increase in beta-catenin tyrosine phosphorylation and prevents loss of endothelial cell-cell contact.","method":"Dominant-negative CRNK expression, phospho-specific Western blot, immunofluorescence, electrical resistance measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative with functional endothelial barrier readout and substrate phosphorylation, single lab","pmids":["15778498"],"is_preprint":false},{"year":2005,"finding":"SAPAP3 (SAP90/PSD-95-Associated Protein-3) interacts with FAK (residues 676-840) and PYK2 in yeast two-hybrid and GST pull-down assays. The three proteins co-distribute with PSD-95 and Src in postsynaptic density sucrose gradient fractions, suggesting SAPAP3 anchors PYK2 in postsynaptic densities.","method":"Yeast two-hybrid, GST pull-down, sucrose gradient fractionation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — yeast two-hybrid plus GST pull-down with biochemical fractionation, single lab","pmids":["16202977"],"is_preprint":false},{"year":2008,"finding":"PCDH-gamma (gamma-protocadherins) binds PYK2 and FAK, and this interaction inhibits kinase activity. PYK2 activity is abnormally upregulated in Pcdh-gamma-deficient neurons. Overexpression of PYK2 induces apoptosis in chicken spinal cord. PCDH-alpha also interacts with PYK2 and FAK despite a distinct cytoplasmic domain; in neural tissue, PCDH-gamma and PCDH-alpha form complexes with PYK2 and/or FAK.","method":"Co-immunoprecipitation, kinase assay in Pcdh-gamma-null neurons, overexpression in chick spinal cord","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with kinase activity measurement in knockout neurons plus gain-of-function, single lab","pmids":["19047047"],"is_preprint":false},{"year":2009,"finding":"Pyk2 phosphorylates and activates PDZ-RhoGEF in vitro. Knockdown of PDZ-RhoGEF reduces RhoA activation by constitutively active Pyk2, placing PDZ-RhoGEF downstream of Pyk2. Knockdown of PYK2 or PDZ-RhoGEF markedly decreases RhoA activation by calcium ionophore A23187, establishing a PYK2/PDZ-RhoGEF/RhoA axis linking Ca2+ signaling to RhoA activation in vascular smooth muscle cells.","method":"In vitro phosphorylation/activation assay, adenoviral knockdown, RhoA translocation assay, Western blot","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro phosphorylation plus genetic knockdown epistasis, single lab","pmids":["19759375"],"is_preprint":false},{"year":2009,"finding":"PYK2 interacts with MyD88 via MyD88's death domain (in vitro and in macrophages). PYK2-deficient macrophages exhibit reduced IκB phosphorylation/degradation, decreased NF-κB activation, and decreased IL-1β expression in response to LPS, placing PYK2 in the LPS-MyD88-NF-κB signaling pathway.","method":"Co-immunoprecipitation, domain mapping (death domain), Western blot in PYK2-deficient macrophages","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain identification plus loss-of-function in macrophages with defined NF-κB readout, single lab","pmids":["19955209"],"is_preprint":false},{"year":2010,"finding":"PSD-95 overexpression in PC6-3 cells induces trans-autophosphorylation of Pyk2 at Tyr402. In neurons, Ca2+ influx through NMDA receptors causes postsynaptic clustering and autophosphorylation of endogenous Pyk2 via Ca2+- and calmodulin-stimulated binding to PSD-95. This Pyk2 activation mechanism is critical for long-term potentiation in hippocampal CA1.","method":"Overexpression, in vitro oligomerization (antibody-induced), calcium imaging, LTP electrophysiology, immunofluorescence in neurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro trans-autophosphorylation assay plus LTP physiology and endogenous protein localization, multiple orthogonal methods, single lab","pmids":["20071509"],"is_preprint":false},{"year":2010,"finding":"Pyk2 interacts with mGluR1 and mGluR5, precipitated from rat brain. Pyk2 associates with the second intracellular loop and distal C-terminal tail of mGluR1a (GST pull-down). Pyk2 overexpression attenuates agonist-stimulated inositol phosphate formation by displacing Galphaq/11 from the receptor. Pyk2 activity (calmodulin-, Src-, and PKC-dependent) is required for mGluR-stimulated ERK1/2 phosphorylation.","method":"Co-immunoprecipitation from rat brain, GST pull-down, IP formation assay, dominant-negative Pyk2, ERK assay","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — brain Co-IP plus GST pull-down domain mapping and functional rescue, single lab","pmids":["20180987"],"is_preprint":false},{"year":2012,"finding":"STEP (striatal-enriched protein-tyrosine phosphatase) binds to Pyk2 and dephosphorylates it at Tyr402. STEP KO mice show enhanced phosphorylation of Pyk2 at Tyr402 and of its substrates paxillin and ASAP1. STEP opposes Pyk2 activation after KCl depolarization and blocks Pyk2 translocation to postsynaptic densities.","method":"Co-immunoprecipitation, phosphatase assay, Western blot in STEP KO mice, biochemical fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro phosphatase assay identifying Pyk2 as STEP substrate plus KO mouse validation with multiple readouts, single lab with multiple methods","pmids":["22544749"],"is_preprint":false},{"year":2015,"finding":"FAK and PYK2 phosphorylate GSK3β at Y216, promoting β-catenin accumulation and Wnt/β-catenin pathway activation, and intestinal tumorigenesis in APCmin/+ mice. Phosphorylation of GSK3β(Y216) acts as a molecular determinant for GSK3β recruitment of β-TrCP. Pharmacological FAK/PYK2 inhibition suppresses adenoma formation in APCmin/+ mice with reduced phospho-GSK3β(Y216) and β-catenin.","method":"In vitro kinase assay, mutagenesis, APCmin/+ mouse model, pharmacological inhibition","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay establishing GSK3β(Y216) as substrate, with in vivo genetic and pharmacological validation in mouse tumor model","pmids":["26274564"],"is_preprint":false},{"year":2015,"finding":"EGF induces rapid phosphorylation of PYK2 and its translocation to early endosomes where it co-localizes with EGFR and sustains downstream signals. PYK2 enhances EGF-induced STAT3 phosphorylation, while phospho-STAT3 directly binds to the PYK2 promoter to regulate PYK2 transcription. PYK2 and STAT3 also enhance c-Met expression, while c-Met augments their phosphorylation, forming a positive feedback loop.","method":"Immunofluorescence/confocal microscopy for co-localization with endosomes, ChIP for STAT3 binding to PYK2 promoter, Western blot, siRNA knockdown","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct endosomal co-localization with functional consequence plus ChIP, single lab","pmids":["25648557"],"is_preprint":false},{"year":2015,"finding":"Pyk2 is required for astrocyte migration after brain lesion. Pyk2-/- astrocytes migrated slower in in vitro wound healing and had delayed actin re-polymerization after latrunculin B treatment. Gelsolin was less enriched at the leading edge of migrating Pyk2-/- astrocytes, suggesting its lack of recruitment partially mediates the migration defect. TNFα-induced Pyk2 phosphorylation at Tyr402 increased PKC activity upstream.","method":"Pyk2 knockout mice, in vivo stab lesion, in vitro wound healing, actin dynamics assay, immunofluorescence","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with multiple localization and functional readouts in vivo and in vitro, single lab","pmids":["26663135"],"is_preprint":false},{"year":2017,"finding":"Pyk2 co-localizes with cortactin at invadopodia and mediates EGF-induced cortactin tyrosine phosphorylation directly and indirectly via Src-mediated Arg kinase activation. This leads to actin polymerization in invadopodia, ECM degradation, and tumor cell invasion. siRNA knockdown and rescue experiments established Pyk2 as regulator of invadopodium-mediated functions, distinct from FAK which regulates focal adhesion-mediated motility.","method":"Protein array screening, Co-immunoprecipitation, siRNA knockdown, in vitro kinase assay, confocal microscopy, invasion assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — protein array identification of cortactin as novel substrate plus in vitro kinase validation, Co-IP, localization, and functional rescue with multiple orthogonal methods","pmids":["29133485"],"is_preprint":false},{"year":2018,"finding":"Pyk2 is a direct tyrosine kinase of tau protein, phosphorylating tau in vitro and in vivo. Pyk2 colocalizes, interacts with, and phosphorylates tau. Pyk2 activity is increased in FynCA (constitutively active Fyn) mice and decreased in FynKO mice, placing Pyk2 downstream of Fyn in a tau phosphorylation cascade.","method":"In vitro kinase assay, Co-immunoprecipitation, transgenic mouse models (Pyk2/tau double transgenic, FynCA, FynKO), Western blot with phospho-tau antibodies","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay establishing tau as Pyk2 substrate plus in vivo genetic epistasis with Fyn, single lab","pmids":["29782321"],"is_preprint":false},{"year":2018,"finding":"Alpha-protocadherins (Pcdha) regulate cortical neuron migration through the WAVE complex, and Pyk2 overexpression impairs cortical neuron migration via inactivation of the small GTPase Rac1, defining a molecular Pcdhα/WAVE/Pyk2/Rac1 axis in actin cytoskeletal dynamics.","method":"Pcdha cluster knockout mice, Pyk2 overexpression, Rac1 activity assay, cortical neuron migration assay","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined pathway placement (Rac1 assay) and functional migration readout, single lab","pmids":["29911975"],"is_preprint":false},{"year":2018,"finding":"PYK2 positively regulates TAZ (and YAP) transcriptional activity in triple-negative breast cancer. PYK2 inhibition or knockdown facilitates proteasomal degradation of TAZ; this is specific to PYK2 and not observed with FAK inhibition. PYK2 enhances tyrosine phosphorylation of both TAZ and LATS1/2, promoting TAZ stability.","method":"siRNA knockdown, kinase inhibitor, Western blot, proteasomal degradation assay, transcriptional reporter","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown plus kinase inhibitor with proteasomal degradation and phosphorylation readouts, FAK-specificity control, single lab","pmids":["30250159"],"is_preprint":false},{"year":2019,"finding":"Pyk2 interacts with the RhoGAP protein Graf1c in brain tissue (biochemical isolation), and Pyk2 kinase activity inhibits Graf1c, thereby activating RhoA. Aβ oligomer-induced reductions in dendritic spine motility and chronic spine loss require both Pyk2 kinase activity and RhoA activation, establishing a Pyk2/Graf1/RhoA pathway in synapse maintenance.","method":"Biochemical isolation of Pyk2-interacting proteins from brain, Co-immunoprecipitation, kinase assay, dendritic spine imaging, RhoA activity assay","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — brain biochemical isolation with functional validation in neurons and RhoA epistasis, single lab","pmids":["30626696"],"is_preprint":false},{"year":2020,"finding":"CD56 (NCAM) on NK cells is functionally linked to Pyk2: CD56-knockout NK92 cells show decreased Pyk2 Tyr402 phosphorylation, impaired lytic granule exocytosis, and impaired immunological synapse polarization. Cytotoxicity, exocytosis, and Pyk2 Tyr402 phosphorylation are all rescued by CD56 re-introduction.","method":"CRISPR/Cas9 knockout of CD56, rescue re-expression, Western blot (phospho-Y402), cytotoxicity assay, granule exocytosis assay, immunological synapse imaging","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean CRISPR KO with rescue, multiple orthogonal functional readouts establishing CD56-Pyk2-exocytosis axis, single lab","pmids":["32510326"],"is_preprint":false},{"year":2020,"finding":"Pyk2 phosphorylates Cx43 (connexin 43) at residues Y247, Y265, Y267, and Y313 (identified by mass spectrometry). Pyk2 can be activated by Src and active Pyk2 interacts with Cx43 at the plasma membrane. Overexpression of Pyk2 increases Cx43 phosphorylation; knockdown decreases it. PMA-induced Pyk2 activation decreases Cx43 gap junction intercellular communication (GJIC), and Pyk2 inhibition partially restores GJIC.","method":"In vitro phosphorylation screen, mass spectrometry, Western blot, immunofluorescence, dye transfer GJIC assay in HeLaCx43 cells and NRVMs","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation with MS identification of specific residues plus functional GJIC assay, single lab with multiple orthogonal methods","pmids":["32956670"],"is_preprint":false},{"year":2021,"finding":"PKM2 promotes Pyk2 activation in macrophages downstream of TLR4, TLR7, and TLR9 pathways. Overexpression of PKM2 promotes TLR-induced Pyk2 activation, while PKM2 inhibition reduces it; co-immunoprecipitation showed PKM2-Pyk2 interaction. Pyk2 inhibitor phenocopied PKM2 inhibition in TLR pathway suppression.","method":"Co-immunoprecipitation, overexpression, siRNA, pharmacological inhibitor (Pyk2 inhibitor), Western blot, cytokine assay","journal":"Frontiers in immunology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP with pharmacological epistasis, single lab, abstract does not detail mechanistic depth","pmids":["34025679"],"is_preprint":false},{"year":2021,"finding":"PYK2 directly phosphorylates IRF5 (demonstrated by kinase inhibitor library screening and PYK2-deficient macrophage experiments). PYK2-deficient macrophages display impaired IRF5 activation and reduced inflammatory gene expression. The PYK2 inhibitor defactinib induces a transcriptomic signature similar to IRF5 deficiency and reduces pro-inflammatory cytokines in human colon biopsies and mouse colitis.","method":"Kinase inhibitor library screen, PYK2-deficient macrophages, transcriptomics, ex vivo human colon biopsy, mouse colitis model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase screen plus genetic KO and pharmacological validation with in vivo and ex vivo disease models, single lab","pmids":["34795257"],"is_preprint":false},{"year":2022,"finding":"PYK2 senses calcium through its kinase-FAT linker (KFL), which is disordered and contains an unusual calmodulin (CaM) binding element. KFL engages CaM through an ensemble of transient interactions, and calcium increases the association by promoting structural changes in CaM exposing auxiliary interaction sites. KFL forms fuzzy dimers that are enhanced by CaM binding. As a monomer, KFL associates with the PYK2 FERM-kinase fragment. CaM-induced dimerization promotes trans-autophosphorylation-based PYK2 activation.","method":"NMR spectroscopy, biophysical binding assays, structural analysis, mutagenesis","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional validation of CaM binding and dimerization mechanism, multiple biophysical methods, single lab","pmids":["35945264"],"is_preprint":false},{"year":2022,"finding":"SIRPα forms a direct interaction with PTK2B/PYK2 through SIRPα's intracellular C-terminal domain, inhibiting PTK2B activation in macrophages. Necroptosis inhibition from SIRPα deficiency requires PTK2B activity, establishing PTK2B as a downstream effector of SIRPα signaling in macrophage homeostasis.","method":"Co-immunoprecipitation, domain mapping, PTK2B activity assay, SIRPα-/- macrophages, necroptosis assay","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain identification plus genetic KO and functional necroptosis readout, single lab","pmids":["36202053"],"is_preprint":false},{"year":2022,"finding":"Pyk2 deletion in PS19 tauopathy mice exacerbates tau phosphorylation, tau accumulation, synapse loss, gliosis, and spatial memory impairment. Endogenous Pyk2 suppresses LKB1 and p38 MAPK activity, providing a mechanism by which Pyk2 loss leads to increased tau pathology. Thus, in tauopathy, endogenous Pyk2 suppresses rather than promotes tau phosphorylation.","method":"Pyk2 conditional knockout in PS19 mice, proteomic profiling, phospho-tau Western blot, LKB1/p38 activity assays, behavioral testing","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in defined tauopathy model with proteomic pathway identification, single lab","pmids":["35501917"],"is_preprint":false},{"year":2023,"finding":"PTK2B directly phosphorylates TBK1 at Tyr591, increasing TBK1 oligomerization and activation. PTK2B also interacts with STING and promotes its oligomerization in a kinase-independent manner. PTK2B depletion reduces antiviral signaling in fibroblasts, macrophages, and dendritic cells, and Ptk2b-deficient mice are more susceptible to viral infection.","method":"In vitro kinase assay, Co-immunoprecipitation, Ptk2b-/- mice, viral infection assay, oligomerization assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay identifying TBK1 Y591 phosphorylation plus genetic KO mice with viral susceptibility and mechanistic oligomerization data, multiple orthogonal methods","pmids":["37989995"],"is_preprint":false},{"year":2023,"finding":"Mettl3/Ythdf2 regulate macrophage inflammation and ROS generation through Pyk2 mRNA stability. Mettl3 and Ythdf2 depletion increased Pyk2 mRNA stability and expression; RIP-PCR showed Ythdf2 directly targets Pyk2 mRNA in a Mettl3-dependent manner. Upregulated inflammatory signaling in Mettl3-knockdown cells was rescued by Pyk2 inhibitor, placing Pyk2 downstream of the Mettl3/Ythdf2 m6A axis.","method":"RNA-seq, RIP-PCR, siRNA knockdown, mRNA stability assay, pharmacological Pyk2 inhibition","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP-PCR establishing direct Ythdf2-Pyk2 mRNA interaction plus functional rescue with Pyk2 inhibitor, single lab","pmids":["37952687"],"is_preprint":false}],"current_model":"PTK2B/PYK2 is a calcium-sensitive, non-receptor tyrosine kinase of the FAK family that is activated by increases in intracellular Ca2+ through a calmodulin-binding disordered linker that promotes trans-autophosphorylation at Tyr402; once activated, it recruits and activates Src-family kinases (which further enhance PYK2 activity and phosphorylate downstream substrates), and functions as a signaling scaffold linking diverse extracellular stimuli (G protein-coupled receptors, integrins, growth factors, stress signals, NMDA receptors) to downstream pathways including JNK, ERK/Ras, p38 MAPK, NF-κB (via MyD88), RhoA (via PDZ-RhoGEF), Wnt/β-catenin (via GSK3β-Y216 phosphorylation), and antiviral innate immunity (via TBK1-Y591 phosphorylation and STING oligomerization), with its activity negatively regulated by STEP phosphatase (which dephosphorylates Tyr402), FIP200 (which binds the kinase domain), protocadherins, and SIRPα, and positively regulated by PSD-95-mediated clustering at postsynaptic densities and by nephrocystin recruitment to cell-matrix adhesions."},"narrative":{"mechanistic_narrative":"PTK2B (PYK2/RAFTK/CADTK) is a calcium-sensitive, non-receptor tyrosine kinase of the FAK family that couples diverse extracellular stimuli to cytoskeletal remodeling, MAP kinase cascades, and immune signaling [PMID:7499242, PMID:8695788, PMID:8670418]. Its activation is gated by intracellular Ca2+: the disordered kinase-FAT linker contains a calmodulin-binding element whose Ca2+-promoted engagement of CaM drives fuzzy dimerization and intermolecular (trans) autophosphorylation specifically at Tyr402, a step that is Src-independent but creates the Src-binding site that amplifies downstream substrate phosphorylation [PMID:15166227, PMID:35945264]. Once activated, PYK2 nucleates signaling complexes by recruiting Src-family kinases, Grb2, and paxillin through its phospho-Tyr and proline-rich/C-terminal domains [PMID:8695788, PMID:9091579, PMID:9560226], and functions both as a kinase and as a scaffold linking integrin, GPCR, growth factor, and stress inputs to JNK, ERK/Ras, and p38 MAPK pathways [PMID:8670418, PMID:9120025, PMID:9774361, PMID:14676843]. PYK2 directly phosphorylates a broad substrate range—the Kv1.2 potassium channel, GSK3β at Tyr216 to activate Wnt/β-catenin signaling and intestinal tumorigenesis, cortactin at invadopodia to promote ECM degradation and invasion, connexin-43 to suppress gap-junction communication, and the antiviral kinase TBK1 at Tyr591 to drive its oligomerization and innate immune signaling [PMID:9560226, PMID:26274564, PMID:29133485, PMID:32956670, PMID:37989995]. It activates the small GTPase RhoA via PDZ-RhoGEF and Graf1, linking Ca2+ to actin dynamics and synapse maintenance [PMID:19759375, PMID:30626696], and operates in macrophage inflammatory signaling through MyD88 and IRF5 [PMID:19955209, PMID:34795257]. PYK2 activity is negatively regulated by the phosphatase STEP, which dephosphorylates Tyr402, by FIP200 binding the kinase domain, and by protocadherins and SIRPα, and is positively organized by PSD-95-mediated postsynaptic clustering downstream of NMDA-receptor Ca2+ influx, where it is required for hippocampal LTP [PMID:10769033, PMID:20071509, PMID:22544749, PMID:19047047, PMID:36202053]. In the brain it phosphorylates tau and contributes to synaptic and tauopathy phenotypes [PMID:29782321, PMID:35501917]. Beyond kinase signaling, PYK2 controls cell migration, spreading, apoptosis, and cell-cycle progression in a manner distinct from FAK and mapped to its N- and C-terminal domains [PMID:10934044, PMID:11062241, PMID:15967096].","teleology":[{"year":1995,"claim":"Establishing that a FAK-related cytoplasmic tyrosine kinase exists outside focal-adhesion receptors answered whether non-integrin stimuli could engage a FAK-like kinase, defining PYK2 as a distinct cytoplasmic enzyme.","evidence":"cDNA cloning and sequence analysis with thrombin-induced phosphorylation in megakaryocytic cells","pmids":["7499242"],"confidence":"Medium","gaps":["No structural basis for activation defined","Substrates and downstream pathways unidentified"]},{"year":1996,"claim":"Showing intrinsic kinase/autokinase activity, fibronectin-induced focal-adhesion localization, and SH2-mediated recruitment of Src, Fyn, and Grb2 established PYK2 as an integrin-responsive scaffold that recruits Src-family kinases.","evidence":"In vitro kinase assay, reciprocal Co-IP, and confocal localization in megakaryocytic and COS cells","pmids":["8695788"],"confidence":"High","gaps":["Autophosphorylation site not defined","Direct substrates not identified"]},{"year":1996,"claim":"Placing PYK2 upstream of JNK in response to TNF-alpha, UV, and osmotic shock connected the kinase to stress-activated signaling, extending its role beyond adhesion.","evidence":"Overexpression and dominant-negative epistasis with JNK activity readout","pmids":["8670418"],"confidence":"High","gaps":["Intermediate signaling components to JNK not resolved","Direct vs scaffold contribution unclear"]},{"year":1997,"claim":"Identifying Ca2+/PKC-dependent, calpain-regulated activation in platelets and TCR-stimulated T cells answered how surface-receptor signals feed into PYK2, linking it to calcium and cytoskeletal integrity across cell types.","evidence":"Platelet and T-cell activation assays, pharmacological dissection, SH2-domain binding and Co-IP","pmids":["9099753","9091579"],"confidence":"Medium","gaps":["Molecular Ca2+ sensor not yet defined","Functional consequences of partner recruitment incomplete"]},{"year":1998,"claim":"Demonstrating GPCR-coupled activation (muscarinic, CCR5, angiotensin II) with substrate phosphorylation of Kv1.2 and downstream Ras/ERK, JNK and p38 established PYK2 as a hub bridging GPCR signaling to ion channels and MAPK cascades.","evidence":"Stable cell lines, site-directed mutagenesis of phospho-tyrosines, in vitro phosphorylation, dominant-negative epistasis, Ras-GTP/ERK assays","pmids":["9560226","9446638","9774361"],"confidence":"High","gaps":["Direct receptor-PYK2 coupling mechanism not defined","Generality of Kv1.2 phosphorylation in vivo untested"]},{"year":1999,"claim":"Linking PYK2 kinase activity to dexamethasone-induced apoptosis in myeloma cells assigned the kinase a pro-apoptotic role in a defined, stimulus-specific death pathway.","evidence":"Transient overexpression and kinase-inactive mutant in apoptosis assays","pmids":["10597281"],"confidence":"Medium","gaps":["Apoptotic effector mechanism downstream of PYK2 not defined","Cell-type generality unknown"]},{"year":2000,"claim":"Identifying FIP200 as a direct kinase-domain inhibitor that dissociates upon stimulation provided the first negative-regulatory mechanism for PYK2.","evidence":"Yeast two-hybrid, in vitro binding and kinase-inhibition assays, Co-IP in SYF cells","pmids":["10769033"],"confidence":"High","gaps":["Structural basis of FIP200-mediated inhibition not resolved","Stimulus-induced dissociation trigger unknown"]},{"year":2000,"claim":"Defining domain-specific control of migration, spreading, cell-cycle, and neurite outgrowth—distinct from FAK and mapped to N- and C-terminal domains—established PYK2's non-redundant cellular roles.","evidence":"Chimeric/domain-deletion constructs, dominant-negative CRNK, motility and flow-cytometry assays in monocytes, PC12, and fibroblasts","pmids":["10980697","10934044","11062241"],"confidence":"High","gaps":["Effectors mediating C-terminal cell-cycle inhibition not identified","Mechanism of cytoplasmic vs focal-adhesion localization difference unclear"]},{"year":2001,"claim":"Identifying nephrocystin-mediated recruitment to cell-matrix adhesions and PI3K/SHP-2 association in platelets clarified how PYK2 is positioned at adhesion complexes and its Tyr402 activation triggered.","evidence":"Co-IP of endogenous complexes, phospho-Y402 Western blot, pharmacological PI3K epistasis, ERK and angiogenesis assays","pmids":["11493697","11472358","11739395"],"confidence":"Medium","gaps":["Direct vs indirect nature of partner interactions not fully resolved","In vivo relevance of complexes untested"]},{"year":2002,"claim":"Establishing PYK2 as a Src-coordinating scaffold phosphorylating p190RhoGAP, PDK1, ARA55, and alpha-synuclein, and as a driver of breast-cancer invasion and cardiomyocyte apoptosis, broadened its substrate repertoire and showed Tyr402 is required for these outputs.","evidence":"Site-directed mutagenesis (Y402, PDK1-Y9), Co-IP, in vitro phosphorylation, invasion and apoptosis assays","pmids":["10713673","11856738","12096713","15322113"],"confidence":"Medium","gaps":["Direct vs Src-relayed phosphorylation of each substrate not always separated","Physiological substrate set incomplete"]},{"year":2003,"claim":"Demonstrating PYK2 scaffolds Src-dependent PDK1 phosphorylation at focal adhesions integrated PYK2 into adhesion-coupled signaling downstream of angiotensin II.","evidence":"Adenoviral expression, PDK1-Y9 mutagenesis, confocal co-localization, Co-IP in vascular smooth muscle","pmids":["14585963"],"confidence":"Medium","gaps":["Downstream PDK1 effector outputs not mapped","Generality beyond VSMC unknown"]},{"year":2004,"claim":"Establishing that autophosphorylation occurs in trans, only at Tyr402, and is Src-independent answered the long-standing mechanism of PYK2 activation and defined the order: trans-autophosphorylation precedes Src recruitment and substrate amplification.","evidence":"Dual-tag constructs, affinity chromatography, in vitro kinase assays in SYF cells, plus VEGF-dependent Ca2+-sensitive p38 pathway dissection","pmids":["15166227","14676843"],"confidence":"High","gaps":["Structural trigger for self-association not yet defined","Stoichiometry of active dimers unresolved"]},{"year":2005,"claim":"Mapping migration stimulation to the N-terminal domain and establishing junctional recruitment with beta-catenin phosphorylation and SAPAP3/PSD-95 anchoring connected PYK2 to barrier function, glioma migration, and postsynaptic positioning.","evidence":"Domain-swap chimeras, siRNA knockdown/rescue, dominant-negative CRNK, junctional imaging, yeast two-hybrid and PSD fractionation","pmids":["15967096","15778498","16202977"],"confidence":"Medium","gaps":["N-terminal effectors driving migration unidentified","Direct vs scaffold role at junctions not fully separated"]},{"year":2008,"claim":"Showing protocadherin binding inhibits PYK2 and that PYK2 is hyperactive in Pcdh-deficient neurons added a developmental, neuron-specific layer of negative regulation.","evidence":"Co-IP, kinase assays in Pcdh-gamma-null neurons, overexpression in chick spinal cord","pmids":["19047047"],"confidence":"Medium","gaps":["Structural basis of protocadherin-mediated inhibition unknown","Direct vs complex-mediated effect not resolved"]},{"year":2009,"claim":"Defining the PYK2/PDZ-RhoGEF/RhoA axis and the MyD88 interaction established how PYK2 converts Ca2+ signals to RhoA activation and links it to innate NF-κB inflammatory signaling.","evidence":"In vitro phosphorylation/activation, knockdown epistasis, RhoA assays, Co-IP with death-domain mapping in macrophages","pmids":["19759375","19955209"],"confidence":"Medium","gaps":["Direct PYK2-MyD88 phosphorylation event not defined","PDZ-RhoGEF phospho-site not mapped"]},{"year":2010,"claim":"Demonstrating PSD-95-driven postsynaptic clustering and Ca2+/CaM-dependent Tyr402 autophosphorylation required for hippocampal LTP, plus mGluR scaffolding, established PYK2 as a key effector of NMDA-receptor calcium signaling in synaptic plasticity.","evidence":"Overexpression, in vitro oligomerization, calcium imaging, LTP electrophysiology, brain Co-IP and GST pull-down","pmids":["20071509","20180987"],"confidence":"High","gaps":["Synaptic substrates mediating LTP not fully defined","Quantitative link between clustering and kinase output incomplete"]},{"year":2012,"claim":"Identifying STEP as a phosphatase that dephosphorylates Tyr402 and blocks postsynaptic translocation defined a key physiological off-switch opposing depolarization-induced PYK2 activation.","evidence":"In vitro phosphatase assay, Co-IP, STEP KO mice with paxillin/ASAP1 substrate readouts and fractionation","pmids":["22544749"],"confidence":"High","gaps":["Regulation of STEP-PYK2 engagement not defined","Other phosphatases not excluded"]},{"year":2015,"claim":"Establishing GSK3β-Y216 as a direct substrate driving Wnt/β-catenin signaling and intestinal tumorigenesis, plus EGFR-endosomal STAT3 feedback and astrocyte migration roles, connected PYK2 to oncogenic transcriptional programs and tissue repair.","evidence":"In vitro kinase assay, mutagenesis, APCmin/+ mouse model with pharmacological inhibition, ChIP, knockout astrocytes","pmids":["26274564","25648557","26663135"],"confidence":"High","gaps":["In vivo relevance of STAT3 feedback loop untested","Gelsolin recruitment mechanism in astrocytes incomplete"]},{"year":2017,"claim":"Identifying cortactin as a direct invadopodial substrate distinguished PYK2 from FAK by assigning it control of invadopodium-mediated ECM degradation and invasion.","evidence":"Protein-array substrate screening, in vitro kinase assay, Co-IP, siRNA knockdown/rescue, invasion assays","pmids":["29133485"],"confidence":"High","gaps":["Relative contribution of direct vs Arg-mediated cortactin phosphorylation not quantified","In vivo metastasis relevance untested"]},{"year":2018,"claim":"Placing PYK2 downstream of Fyn as a direct tau kinase and within a Pcdha/WAVE/Rac1 neuronal migration axis extended its substrate range into neurodegeneration-relevant and developmental pathways.","evidence":"In vitro kinase assays, Co-IP, FynCA/FynKO and Pcdha-cluster knockout mice, Rac1 activity and migration assays","pmids":["29782321","29911975"],"confidence":"Medium","gaps":["Tau phosphosites and pathological consequence in vivo not fully resolved at this stage","Mechanism of Rac1 inactivation by PYK2 unclear"]},{"year":2018,"claim":"Identifying PYK2 as a positive regulator of TAZ/YAP stability in triple-negative breast cancer assigned a FAK-independent role in Hippo-pathway transcriptional output.","evidence":"siRNA knockdown, kinase inhibitor with FAK-specificity control, proteasomal-degradation and reporter assays","pmids":["30250159"],"confidence":"Medium","gaps":["Direct TAZ/LATS phosphosites not mapped","In vivo tumor relevance untested"]},{"year":2019,"claim":"Defining a PYK2/Graf1/RhoA pathway required for amyloid-beta-induced spine loss linked PYK2 RhoGAP inhibition to synapse maintenance in neurodegeneration.","evidence":"Brain biochemical isolation, Co-IP, kinase assay, dendritic-spine imaging and RhoA activity assay","pmids":["30626696"],"confidence":"Medium","gaps":["Graf1 phosphosite not identified","Direct vs indirect inhibition of Graf1c unresolved"]},{"year":2020,"claim":"Mapping connexin-43 phosphosites and the CD56-PYK2 axis in NK cells connected PYK2 to gap-junction communication and immune-synapse-driven cytotoxic granule exocytosis.","evidence":"In vitro phosphorylation with mass spectrometry, GJIC dye-transfer assays, CRISPR CD56 knockout/rescue with cytotoxicity and synapse imaging","pmids":["32956670","32510326"],"confidence":"High","gaps":["How CD56 couples to PYK2 Tyr402 phosphorylation not defined","Functional consequence of each Cx43 phosphosite not separated"]},{"year":2022,"claim":"Resolving that the disordered kinase-FAT linker binds calmodulin and that Ca2+ promotes CaM-induced fuzzy dimerization driving trans-autophosphorylation provided the structural mechanism for calcium-sensing activation, unifying decades of Ca2+-dependence observations.","evidence":"NMR spectroscopy, biophysical binding assays, mutagenesis of the KFL/FERM-kinase fragment","pmids":["35945264"],"confidence":"High","gaps":["Full-length activated complex structure not determined","Quantitative coupling of dimer formation to cellular activity incomplete"]},{"year":2022,"claim":"Identifying SIRPα as a direct C-terminal inhibitor of PYK2 controlling macrophage necroptosis added a receptor-coupled negative-regulatory mechanism in myeloid homeostasis.","evidence":"Co-IP with domain mapping, PYK2 activity assay, SIRPα-null macrophages, necroptosis assay","pmids":["36202053"],"confidence":"Medium","gaps":["Structural basis of inhibition not resolved","Downstream necroptosis effector pathway from PYK2 incomplete"]},{"year":2022,"claim":"Showing Pyk2 deletion worsens tauopathy by relieving its suppression of LKB1/p38 reframed PYK2 as a context-dependent suppressor of tau pathology, in apparent contrast to its direct tau-kinase activity.","evidence":"Conditional Pyk2 knockout in PS19 mice, proteomics, phospho-tau Western blot, LKB1/p38 activity assays, behavior","pmids":["35501917"],"confidence":"Medium","gaps":["Reconciliation of direct tau phosphorylation with net protective role unresolved","Mechanism of LKB1/p38 suppression not defined"]},{"year":2023,"claim":"Establishing PYK2 as a direct TBK1-Y591 kinase that also drives STING oligomerization kinase-independently defined a non-redundant role in antiviral innate immunity, with knockout mice showing increased viral susceptibility.","evidence":"In vitro kinase assay, Co-IP, oligomerization assays, Ptk2b-/- mice and viral infection","pmids":["37989995"],"confidence":"High","gaps":["Structural basis of kinase-independent STING oligomerization unclear","Upstream trigger for antiviral PYK2 activation not defined"]},{"year":2023,"claim":"Defining IRF5 as a direct PYK2 substrate and showing m6A/Mettl3/Ythdf2 control of Pyk2 mRNA stability connected the kinase to transcriptional control of macrophage inflammation and to post-transcriptional regulation of its own abundance.","evidence":"Kinase inhibitor library screen, PYK2-deficient macrophages, transcriptomics, colitis models, RIP-PCR and mRNA-stability assays","pmids":["34795257","37952687"],"confidence":"Medium","gaps":["IRF5 phosphosites not mapped","Upstream signals controlling m6A-mediated Pyk2 regulation unknown"]},{"year":null,"claim":"How the many context-dependent and even opposing outputs of PYK2 (pro- vs anti-tumorigenic, pro- vs anti-tau-pathology, kinase-dependent vs scaffold roles) are selected within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model of how stimulus identity dictates which PYK2 substrate/scaffold output dominates","Full-length structures of activated PYK2 complexes lacking","In vivo substrate hierarchy across tissues undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,7,23,34,37,43,49]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[1,23]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[46,31]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,4,7,49]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13,11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[35]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[26,43]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8,24,29,34]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[30,42,45,49]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[31,32,38,41]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[34,37,40]}],"complexes":["postsynaptic density"],"partners":["SRC","FYN","GRB2","PXN","FIP200","PTPN5","MYD88","SIRPA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14289","full_name":"Protein-tyrosine kinase 2-beta","aliases":["Calcium-dependent tyrosine kinase","CADTK","Calcium-regulated non-receptor proline-rich tyrosine kinase","Cell adhesion kinase beta","CAK-beta","CAKB","Focal adhesion kinase 2","FADK 2","Proline-rich tyrosine kinase 2","Related adhesion focal tyrosine kinase","RAFTK"],"length_aa":1009,"mass_kda":115.9,"function":"Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response, and is required for normal levels of marginal B-cells in the spleen and normal migration of splenic B-cells. Required for normal macrophage polarization and migration towards sites of inflammation. Regulates cytoskeleton rearrangement and cell spreading in T-cells, and contributes to the regulation of T-cell responses. Promotes osteoclastic bone resorption; this requires both PTK2B/PYK2 and SRC. May inhibit differentiation and activity of osteoprogenitor cells. Functions in signaling downstream of integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCR), cytokine, chemokine and growth factor receptors, and mediates responses to cellular stress. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Promotes activation of NOS3. Regulates production of the cellular messenger cGMP. Promotes activation of the MAP kinase signaling cascade, including activation of MAPK1/ERK2, MAPK3/ERK1 and MAPK8/JNK1. Promotes activation of Rho family GTPases, such as RHOA and RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Acts as a scaffold, binding to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at 'Tyr-9, 'Tyr-373', and 'Tyr-376'. Promotes phosphorylation of NMDA receptors by SRC family members, and thereby contributes to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. May also regulate potassium ion transport by phosphorylation of potassium channel subunits. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ASAP1, NPHP1, KCNA2 and SHC1. Promotes phosphorylation of ASAP2, RHOU and PXN; this requires both SRC and PTK2/PYK2","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Cell membrane; Cell junction, focal adhesion; Cell projection, lamellipodium; Cytoplasm, cell cortex; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14289/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PTK2B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PTK2B","total_profiled":1310},"omim":[{"mim_id":"611413","title":"DISCS LARGE-ASSOCIATED PROTEIN 3; DLGAP3","url":"https://www.omim.org/entry/611413"},{"mim_id":"610424","title":"HEPATITIS B VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/610424"},{"mim_id":"608794","title":"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1; PITPNM1","url":"https://www.omim.org/entry/608794"},{"mim_id":"607215","title":"NEPHROCYSTIN 4; NPHP4","url":"https://www.omim.org/entry/607215"},{"mim_id":"607100","title":"NEPHROCYSTIN 1; NPHP1","url":"https://www.omim.org/entry/607100"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":100.4},{"tissue":"brain","ntpm":136.7}],"url":"https://www.proteinatlas.org/search/PTK2B"},"hgnc":{"alias_symbol":["CAKB","PYK2","RAFTK","PTK","CADTK"],"prev_symbol":["FAK2"]},"alphafold":{"accession":"Q14289","domains":[{"cath_id":"3.10.20.90","chopping":"39-143","consensus_level":"high","plddt":86.9128,"start":39,"end":143},{"cath_id":"1.20.80.10","chopping":"168-256","consensus_level":"medium","plddt":90.4578,"start":168,"end":256},{"cath_id":"2.30.29.30","chopping":"264-356","consensus_level":"medium","plddt":90.0794,"start":264,"end":356},{"cath_id":"3.30.200.20","chopping":"417-504","consensus_level":"high","plddt":84.1289,"start":417,"end":504},{"cath_id":"1.10.510.10","chopping":"509-689","consensus_level":"high","plddt":88.1004,"start":509,"end":689},{"cath_id":"1.20.120.330","chopping":"880-1002","consensus_level":"high","plddt":90.6867,"start":880,"end":1002}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14289","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14289-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14289-F1-predicted_aligned_error_v6.png","plddt_mean":76.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PTK2B","jax_strain_url":"https://www.jax.org/strain/search?query=PTK2B"},"sequence":{"accession":"Q14289","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14289.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14289/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14289"}},"corpus_meta":[{"pmid":"10704819","id":"PMC_10704819","title":"RAFTK/Pyk2-mediated cellular signalling.","date":"2000","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/10704819","citation_count":399,"is_preprint":false},{"pmid":"7499242","id":"PMC_7499242","title":"Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7499242","citation_count":322,"is_preprint":false},{"pmid":"8670418","id":"PMC_8670418","title":"Activation of Pyk2 by stress signals and coupling with JNK signaling pathway.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8670418","citation_count":282,"is_preprint":false},{"pmid":"14976243","id":"PMC_14976243","title":"Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14976243","citation_count":214,"is_preprint":false},{"pmid":"10980697","id":"PMC_10980697","title":"Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10980697","citation_count":184,"is_preprint":false},{"pmid":"10354603","id":"PMC_10354603","title":"FAK and PYK2/CAKbeta in the nervous system: a link between neuronal activity, plasticity and survival?","date":"1999","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/10354603","citation_count":165,"is_preprint":false},{"pmid":"8695788","id":"PMC_8695788","title":"Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8695788","citation_count":154,"is_preprint":false},{"pmid":"15967096","id":"PMC_15967096","title":"The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.","date":"2005","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15967096","citation_count":115,"is_preprint":false},{"pmid":"26274564","id":"PMC_26274564","title":"FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26274564","citation_count":108,"is_preprint":false},{"pmid":"9446638","id":"PMC_9446638","title":"Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9446638","citation_count":107,"is_preprint":false},{"pmid":"15166227","id":"PMC_15166227","title":"RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15166227","citation_count":105,"is_preprint":false},{"pmid":"15778498","id":"PMC_15778498","title":"Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15778498","citation_count":97,"is_preprint":false},{"pmid":"10597281","id":"PMC_10597281","title":"RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10597281","citation_count":96,"is_preprint":false},{"pmid":"9560226","id":"PMC_9560226","title":"Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9560226","citation_count":92,"is_preprint":false},{"pmid":"11493697","id":"PMC_11493697","title":"Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggers phosphorylation of Pyk2.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11493697","citation_count":90,"is_preprint":false},{"pmid":"20001213","id":"PMC_20001213","title":"Targeting Pyk2 for therapeutic intervention.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/20001213","citation_count":89,"is_preprint":false},{"pmid":"10713673","id":"PMC_10713673","title":"RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10713673","citation_count":87,"is_preprint":false},{"pmid":"9091579","id":"PMC_9091579","title":"RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9091579","citation_count":87,"is_preprint":false},{"pmid":"21132400","id":"PMC_21132400","title":"Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation.","date":"2010","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21132400","citation_count":79,"is_preprint":false},{"pmid":"19047047","id":"PMC_19047047","title":"alpha- and gamma-Protocadherins negatively regulate PYK2.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19047047","citation_count":72,"is_preprint":false},{"pmid":"14585963","id":"PMC_14585963","title":"Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14585963","citation_count":71,"is_preprint":false},{"pmid":"9774361","id":"PMC_9774361","title":"Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II induced Ras/ERK signaling.","date":"1998","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/9774361","citation_count":70,"is_preprint":false},{"pmid":"9099753","id":"PMC_9099753","title":"Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9099753","citation_count":70,"is_preprint":false},{"pmid":"22544749","id":"PMC_22544749","title":"Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22544749","citation_count":70,"is_preprint":false},{"pmid":"10934044","id":"PMC_10934044","title":"Pyk2 and FAK differentially regulate progression of the cell cycle.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10934044","citation_count":70,"is_preprint":false},{"pmid":"11851354","id":"PMC_11851354","title":"Role of EGF Receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes.","date":"2002","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11851354","citation_count":68,"is_preprint":false},{"pmid":"10769033","id":"PMC_10769033","title":"Suppression of Pyk2 kinase and cellular activities by FIP200.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10769033","citation_count":66,"is_preprint":false},{"pmid":"11278444","id":"PMC_11278444","title":"Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278444","citation_count":66,"is_preprint":false},{"pmid":"25648557","id":"PMC_25648557","title":"PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25648557","citation_count":65,"is_preprint":false},{"pmid":"20071509","id":"PMC_20071509","title":"Postsynaptic clustering and activation of Pyk2 by PSD-95.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20071509","citation_count":65,"is_preprint":false},{"pmid":"16019438","id":"PMC_16019438","title":"Negative regulation of PTK signalling by Cbl proteins.","date":"2005","source":"Growth factors (Chur, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/16019438","citation_count":60,"is_preprint":false},{"pmid":"14676843","id":"PMC_14676843","title":"Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14676843","citation_count":60,"is_preprint":false},{"pmid":"9120025","id":"PMC_9120025","title":"Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9120025","citation_count":60,"is_preprint":false},{"pmid":"29891810","id":"PMC_29891810","title":"Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/29891810","citation_count":58,"is_preprint":false},{"pmid":"14977542","id":"PMC_14977542","title":"Regulation of endothelial cell function BY FAK and PYK2.","date":"2004","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/14977542","citation_count":58,"is_preprint":false},{"pmid":"25217697","id":"PMC_25217697","title":"Pyk2 promotes tumor progression in multiple myeloma.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25217697","citation_count":56,"is_preprint":false},{"pmid":"19759375","id":"PMC_19759375","title":"PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA.","date":"2009","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19759375","citation_count":56,"is_preprint":false},{"pmid":"29133485","id":"PMC_29133485","title":"Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29133485","citation_count":55,"is_preprint":false},{"pmid":"9488700","id":"PMC_9488700","title":"Paxillin phosphorylation and association with Lck and Pyk2 in anti-CD3- or anti-CD45-stimulated T cells.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9488700","citation_count":55,"is_preprint":false},{"pmid":"10764815","id":"PMC_10764815","title":"Characterization of the tyrosine kinases RAFTK/Pyk2 and FAK in nerve growth factor-induced neuronal differentiation.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10764815","citation_count":52,"is_preprint":false},{"pmid":"32510326","id":"PMC_32510326","title":"CD56 regulates human NK cell cytotoxicity through Pyk2.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32510326","citation_count":51,"is_preprint":false},{"pmid":"15322113","id":"PMC_15322113","title":"Cardiomyocyte apoptosis triggered by RAFTK/pyk2 via Src kinase is antagonized by paxillin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15322113","citation_count":50,"is_preprint":false},{"pmid":"29803828","id":"PMC_29803828","title":"PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.","date":"2018","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29803828","citation_count":48,"is_preprint":false},{"pmid":"34690733","id":"PMC_34690733","title":"The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases.","date":"2021","source":"Frontiers in synaptic neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34690733","citation_count":48,"is_preprint":false},{"pmid":"9405454","id":"PMC_9405454","title":"Activation of protein-tyrosine kinase Pyk2 is downstream of Syk in FcepsilonRI signaling.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9405454","citation_count":47,"is_preprint":false},{"pmid":"11062241","id":"PMC_11062241","title":"Inhibition of the calcium-dependent tyrosine kinase (CADTK) blocks monocyte spreading and motility.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11062241","citation_count":46,"is_preprint":false},{"pmid":"29911975","id":"PMC_29911975","title":"Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29911975","citation_count":46,"is_preprint":false},{"pmid":"11856738","id":"PMC_11856738","title":"Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11856738","citation_count":46,"is_preprint":false},{"pmid":"9573036","id":"PMC_9573036","title":"The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9573036","citation_count":45,"is_preprint":false},{"pmid":"24142406","id":"PMC_24142406","title":"Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24142406","citation_count":43,"is_preprint":false},{"pmid":"30626696","id":"PMC_30626696","title":"Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30626696","citation_count":43,"is_preprint":false},{"pmid":"30425234","id":"PMC_30425234","title":"Role of Pyk2 in Human Cancers.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/30425234","citation_count":42,"is_preprint":false},{"pmid":"12228222","id":"PMC_12228222","title":"Activation of pyk2/related focal adhesion tyrosine kinase and focal adhesion kinase in cardiac remodeling.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12228222","citation_count":42,"is_preprint":false},{"pmid":"34025679","id":"PMC_34025679","title":"Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34025679","citation_count":41,"is_preprint":false},{"pmid":"11739395","id":"PMC_11739395","title":"Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11739395","citation_count":40,"is_preprint":false},{"pmid":"26387544","id":"PMC_26387544","title":"Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26387544","citation_count":38,"is_preprint":false},{"pmid":"18390748","id":"PMC_18390748","title":"The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18390748","citation_count":38,"is_preprint":false},{"pmid":"11343423","id":"PMC_11343423","title":"Pyk2 expression and phosphorylation in neonatal and adult cardiomyocytes.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11343423","citation_count":37,"is_preprint":false},{"pmid":"29782321","id":"PMC_29782321","title":"Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.","date":"2018","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/29782321","citation_count":37,"is_preprint":false},{"pmid":"17882150","id":"PMC_17882150","title":"The acid-activated signaling pathway: starting with Pyk2 and ending with increased NHE3 activity.","date":"2007","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/17882150","citation_count":37,"is_preprint":false},{"pmid":"20180987","id":"PMC_20180987","title":"Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation.","date":"2010","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/20180987","citation_count":36,"is_preprint":false},{"pmid":"25594051","id":"PMC_25594051","title":"Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.","date":"2014","source":"Oncoscience","url":"https://pubmed.ncbi.nlm.nih.gov/25594051","citation_count":35,"is_preprint":false},{"pmid":"38247340","id":"PMC_38247340","title":"Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells.","date":"2024","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38247340","citation_count":34,"is_preprint":false},{"pmid":"12096713","id":"PMC_12096713","title":"Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12096713","citation_count":34,"is_preprint":false},{"pmid":"20511342","id":"PMC_20511342","title":"Stretch augments TGF-beta1 expression through RhoA/ROCK1/2, PTK, and PI3K in airway smooth muscle cells.","date":"2010","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20511342","citation_count":34,"is_preprint":false},{"pmid":"10637436","id":"PMC_10637436","title":"From PTK-STAT signaling to caspase expression and apoptosis induction.","date":"1999","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10637436","citation_count":33,"is_preprint":false},{"pmid":"19955209","id":"PMC_19955209","title":"PYK2 interacts with MyD88 and regulates MyD88-mediated NF-kappaB activation in macrophages.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/19955209","citation_count":33,"is_preprint":false},{"pmid":"35228997","id":"PMC_35228997","title":"Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.","date":"2022","source":"Journal of orthopaedic translation","url":"https://pubmed.ncbi.nlm.nih.gov/35228997","citation_count":33,"is_preprint":false},{"pmid":"35501917","id":"PMC_35501917","title":"Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.","date":"2022","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/35501917","citation_count":32,"is_preprint":false},{"pmid":"30250159","id":"PMC_30250159","title":"PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30250159","citation_count":32,"is_preprint":false},{"pmid":"12793995","id":"PMC_12793995","title":"Differential role of PTK and ERK MAPK in superoxide impairment of K(ATP) and K(Ca) channel cerebrovasodilation.","date":"2003","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12793995","citation_count":31,"is_preprint":false},{"pmid":"19706464","id":"PMC_19706464","title":"Src family protein tyrosine kinase (PTK) modulates the effect of SGK1 and WNK4 on ROMK channels.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19706464","citation_count":31,"is_preprint":false},{"pmid":"19415692","id":"PMC_19415692","title":"Prolactin induces chitotriosidase expression in human macrophages through PTK, PI3-K, and MAPK pathways.","date":"2009","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19415692","citation_count":30,"is_preprint":false},{"pmid":"34795257","id":"PMC_34795257","title":"Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34795257","citation_count":27,"is_preprint":false},{"pmid":"26663135","id":"PMC_26663135","title":"Pyk2 is essential for astrocytes mobility following brain lesion.","date":"2015","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/26663135","citation_count":26,"is_preprint":false},{"pmid":"9402324","id":"PMC_9402324","title":"Characterization of the novel focal adhesion kinase RAFTK in hematopoietic cells.","date":"1997","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/9402324","citation_count":25,"is_preprint":false},{"pmid":"26552846","id":"PMC_26552846","title":"Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.","date":"2015","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26552846","citation_count":25,"is_preprint":false},{"pmid":"30664624","id":"PMC_30664624","title":"Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related micro-structural changes.","date":"2019","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30664624","citation_count":25,"is_preprint":false},{"pmid":"12957821","id":"PMC_12957821","title":"PYK2 and FAK in osteoclasts.","date":"2003","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/12957821","citation_count":23,"is_preprint":false},{"pmid":"36202053","id":"PMC_36202053","title":"SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.","date":"2022","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/36202053","citation_count":23,"is_preprint":false},{"pmid":"31118051","id":"PMC_31118051","title":"PYK2 promotes HER2-positive breast cancer invasion.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31118051","citation_count":23,"is_preprint":false},{"pmid":"37586982","id":"PMC_37586982","title":"PYK2, a hub of signaling networks in breast cancer progression.","date":"2023","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37586982","citation_count":22,"is_preprint":false},{"pmid":"11472358","id":"PMC_11472358","title":"RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3-kinase.","date":"2001","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11472358","citation_count":22,"is_preprint":false},{"pmid":"9393984","id":"PMC_9393984","title":"v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9393984","citation_count":22,"is_preprint":false},{"pmid":"17391778","id":"PMC_17391778","title":"Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes.","date":"2007","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/17391778","citation_count":22,"is_preprint":false},{"pmid":"35178052","id":"PMC_35178052","title":"Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35178052","citation_count":21,"is_preprint":false},{"pmid":"16202977","id":"PMC_16202977","title":"FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16202977","citation_count":21,"is_preprint":false},{"pmid":"31447828","id":"PMC_31447828","title":"Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31447828","citation_count":21,"is_preprint":false},{"pmid":"18211905","id":"PMC_18211905","title":"Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18211905","citation_count":21,"is_preprint":false},{"pmid":"22447931","id":"PMC_22447931","title":"Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22447931","citation_count":21,"is_preprint":false},{"pmid":"26848986","id":"PMC_26848986","title":"The Tyrosine Kinase Pyk2 Contributes to Complement-Mediated Phagocytosis in Murine Macrophages.","date":"2016","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26848986","citation_count":21,"is_preprint":false},{"pmid":"34944779","id":"PMC_34944779","title":"Microglial Cytokines Induce Invasiveness and Proliferation of Human Glioblastoma through Pyk2 and FAK Activation.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34944779","citation_count":21,"is_preprint":false},{"pmid":"37989995","id":"PMC_37989995","title":"PTK2B promotes TBK1 and STING oligomerization and enhances the STING-TBK1 signaling.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37989995","citation_count":20,"is_preprint":false},{"pmid":"37952687","id":"PMC_37952687","title":"Mettl3/Ythdf2 regulate macrophage inflammation and ROS generation by controlling Pyk2 mRNA stability.","date":"2023","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/37952687","citation_count":20,"is_preprint":false},{"pmid":"32956670","id":"PMC_32956670","title":"Inhibition of Pyk2 and Src activity improves Cx43 gap junction intercellular communication.","date":"2020","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/32956670","citation_count":19,"is_preprint":false},{"pmid":"12400610","id":"PMC_12400610","title":"The role of Aktand RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells.","date":"2002","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/12400610","citation_count":19,"is_preprint":false},{"pmid":"27080426","id":"PMC_27080426","title":"Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses.","date":"2016","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/27080426","citation_count":18,"is_preprint":false},{"pmid":"35945264","id":"PMC_35945264","title":"PYK2 senses calcium through a disordered dimerization and calmodulin-binding element.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35945264","citation_count":18,"is_preprint":false},{"pmid":"36555115","id":"PMC_36555115","title":"Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36555115","citation_count":18,"is_preprint":false},{"pmid":"12063569","id":"PMC_12063569","title":"Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.","date":"2002","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12063569","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51278,"output_tokens":13678,"usd":0.179502,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":25533,"output_tokens":8606,"usd":0.171407,"stage2_stop_reason":"end_turn"},"total_usd":0.350909,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"RAFTK/PYK2 was identified as a novel cytoplasmic tyrosine kinase (1009 aa) related to FAK, lacking transmembrane regions, myristylation sites, and SH2/SH3 domains, but containing a kinase domain flanked by large N- and C-terminal domains with a proline-rich C-terminal stretch. It is expressed in megakaryocytes and brain, and thrombin stimulation of megakaryocytic CMK cells induced rapid tyrosine phosphorylation of the ~123-kDa RAFTK protein.\",\n      \"method\": \"cDNA cloning, sequence analysis, immunoprecipitation, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — original characterization using immunoprecipitation and Western blot with functional phosphorylation readout, single lab\",\n      \"pmids\": [\"7499242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RAFTK/PYK2 has intrinsic tyrosine kinase and autokinase activities. It localizes to focal adhesion-like structures (co-localizing with vinculin) upon fibronectin activation in megakaryocytic CMK cells and transfected COS cells. Its SH2 domains of Src, Fyn, and adaptor Grb2 associate specifically with tyrosine-phosphorylated RAFTK. Fibronectin-induced integrin signaling triggers RAFTK phosphorylation, and dephosphorylation occurs upon cell detachment with re-phosphorylation upon replating on fibronectin.\",\n      \"method\": \"In vitro kinase assay, immunoprecipitation, confocal microscopy, transfection of COS cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay plus reciprocal Co-IP and direct localization, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"8695788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Pyk2 is activated by stress signals including TNF-alpha, UV irradiation, and osmotic shock, and overexpression of Pyk2 leads to JNK activation. A dominant-negative Pyk2 mutant interferes with UV- or osmotic shock-induced JNK activation, placing Pyk2 upstream of JNK in stress signaling.\",\n      \"method\": \"Overexpression, dominant-negative mutant, kinase activity assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis and gain-of-function overexpression with JNK activity readout, published in high-tier journal, single lab\",\n      \"pmids\": [\"8670418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RAFTK is tyrosine-phosphorylated rapidly (within 10 s) during early platelet activation by thrombin in an integrin glycoprotein IIb-IIIa-independent manner. RAFTK phosphorylation is calcium-dependent, regulated by protein kinase C, requires intact actin cytoskeleton (blocked by cytochalasin D), and occurs independently of platelet aggregation. RAFTK is proteolytically cleaved by calpain in an aggregation-dependent manner.\",\n      \"method\": \"Platelet activation assays, immunoprecipitation, Western blot, pharmacological inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological dissection approaches in primary platelets, single lab\",\n      \"pmids\": [\"9099753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RAFTK is phosphorylated and its kinase activity increases upon T cell receptor (TCR) activation in human T cells. After TCR stimulation, Fyn and Grb2 associate with phospho-RAFTK via their SH2 domains; RAFTK also co-immunoprecipitates with Lck SH2 domain and with paxillin via its C-terminal proline-rich domain. Cytochalasin D pretreatment reduces RAFTK phosphorylation, implicating cytoskeletal integrity in this process.\",\n      \"method\": \"Immunoprecipitation, kinase assay, SH2 domain binding, Western blot\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and SH2 domain binding assays, single lab\",\n      \"pmids\": [\"9091579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RAFTK activation in Kaposi's sarcoma cells by multiple cytokines (bFGF, VEGF, VRP, OSM, IL-6, TNF-alpha) leads to its association with paxillin via the hydrophobic C-terminal domain of the kinase, and downstream JNK activation.\",\n      \"method\": \"Immunoprecipitation, kinase assay, Western blot\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP identifying paxillin as C-terminal domain binding partner, single lab, single method for domain mapping\",\n      \"pmids\": [\"9120025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MIP-1β binding to CCR5 activates RAFTK, with subsequent activation of paxillin, JNK/SAPK, and p38 MAPK. A dominant-negative RAFTK kinase mutant markedly attenuates JNK/SAPK activity downstream of CCR5, placing RAFTK as a functional bridge linking CCR5 receptor signaling to the cytoskeleton and nucleus.\",\n      \"method\": \"Dominant-negative mutant, kinase assay, Western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis with defined downstream readouts, single lab\",\n      \"pmids\": [\"9446638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"m1 muscarinic acetylcholine receptor activation stimulates PYK2 tyrosine kinase activity. Two specific tyrosine residues on PYK2 are phosphorylated upon muscarinic signaling, inducing binding of c-Src and Grb2 to PYK2. PYK2 specifically phosphorylates the C-terminal cytosolic portion of potassium channel Kv1.2 in an m1 receptor-regulated manner. Paxillin associates constitutively with PYK2 independent of muscarinic signaling.\",\n      \"method\": \"Stable cell lines, kinase assay, site-directed mutagenesis of phosphorylation sites, in vitro phosphorylation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with substrate identification (Kv1.2), mutagenesis of phospho-tyrosines, and binding partner identification (Src, Grb2), multiple orthogonal methods\",\n      \"pmids\": [\"9560226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"In cardiac fibroblasts, angiotensin II activates Pyk2/CAKbeta/RAFTK in a Ca2+/calmodulin-sensitive manner. Overexpression of dominant-negative Pyk2 significantly attenuates Ang II- or calcium ionophore-induced ERK activities and GTP-Ras loading, placing Pyk2 upstream of the Ras/ERK pathway downstream of Ang II.\",\n      \"method\": \"Dominant-negative overexpression, ERK kinase assay, Ras-GTP loading assay, pharmacological inhibitors\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis with Ras-GTP and ERK readouts, single lab\",\n      \"pmids\": [\"9774361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RAFTK/Pyk2 activation is required for dexamethasone-induced apoptosis in multiple myeloma cells. Wild-type RAFTK overexpression induces apoptosis, while kinase-inactive RAFTK blocks dexamethasone-induced apoptosis but not IR- or Fas-mediated apoptosis. IL-6 inhibits both RAFTK activation and dexamethasone-triggered apoptosis.\",\n      \"method\": \"Transient overexpression, kinase-inactive mutant, apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-inactive mutant rescue and gain-of-function in defined apoptosis pathway, single lab\",\n      \"pmids\": [\"10597281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Pyk2 and FAK associate with EGF receptor-containing adhesion complexes through their C- and N-terminal domains, respectively, during neurite outgrowth. Expression of the C-terminal domain of Pyk2 or FAK blocks neurite outgrowth but not ERK activation. Autophosphorylation of Pyk2/FAK and phosphorylation of paxillin are required for neurite formation.\",\n      \"method\": \"Overexpression of domain constructs, immunoprecipitation, morphological assay in PC12 and SH-SY5Y cells\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-deletion analysis with defined neurite outgrowth phenotype and receptor complex Co-IP, single lab\",\n      \"pmids\": [\"10980697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RAFTK/Pyk2 tyrosine phosphorylation upon NGF stimulation requires phospholipase Cγ activity and intracellular Ca2+. Paxillin co-immunoprecipitates with RAFTK and its phosphorylation is Ca2+-dependent. By confocal microscopy, RAFTK translocates from cytoplasm to neurite initiation sites at the cell periphery within 5 min, where it co-localizes with paxillin and actin. Potassium depolarization induces RAFTK and paxillin phosphorylation in a Ca2+-dependent manner.\",\n      \"method\": \"Immunoprecipitation, confocal microscopy, pharmacological inhibitors, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence (neurite initiation) and Co-IP, single lab\",\n      \"pmids\": [\"10764815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FIP200 (FAK family kinase-interacting protein of 200 kDa) was identified as a Pyk2-interacting protein that binds the kinase domain of Pyk2 and inhibits its kinase activity in vitro. FIP200 inhibits Pyk2 kinase activity isolated from SYF cells (Src/Yes/Fyn deficient) and a Pyk2 mutant lacking the Src binding site, indicating direct inhibition. Activation of Pyk2 by biological stimuli correlates with dissociation of the endogenous FIP200-Pyk2 complex. FIP200 also inhibits Pyk2-induced apoptosis in intact cells.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, Co-immunoprecipitation, in vitro kinase assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase inhibition assay plus Co-IP and cellular functional assays, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"10769033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Pyk2 inhibits G1-to-S phase transition (whereas FAK promotes it). This differential cell cycle regulation maps to the C-terminal domain of Pyk2 (chimeric PFhy1 with Pyk2 N-term/FAK C-term promotes cell cycle; FPhy2 with FAK N-term/Pyk2 C-term inhibits it). Pyk2 and FPhy2 stimulate JNK activation while inhibiting ERK activation in adhesion, linking these pathway differences to cell cycle outcomes. Pyk2 localizes to cytoplasm (not focal contacts), unlike FAK.\",\n      \"method\": \"Tetracycline-regulated expression, chimeric constructs, flow cytometry, kinase assays, immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chimeric domain-swap constructs with cell cycle and signaling readouts, single lab with multiple methods\",\n      \"pmids\": [\"10934044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CADTK/Pyk2 localizes to the leading edge and ruffling lamellipodia of adherent human monocytes. Introduction of the dominant-negative C-terminal fragment CRNK inhibits CADTK autophosphorylation, reduces cell spreading, inhibits adhesion-induced phosphotyrosine increases and ERK activation, and reduces monocyte motility (from 83% to 26% motile cells). CRNK introduction does not affect phagocytosis or adhesion-induced cytokine gene induction.\",\n      \"method\": \"Immunocytochemistry, electroporation of dominant-negative construct (GST-CRNK), motility assay, ERK assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative with multiple orthogonal functional readouts (localization, spreading, ERK, motility) and negative controls, single lab\",\n      \"pmids\": [\"11062241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Nephrocystin forms protein complexes with Pyk2, p130(Cas), and tensin as shown by immunoprecipitation of native nephrocystin. Expression of nephrocystin results in phosphorylation of Pyk2 at tyrosine 402 and activation of downstream ERK1 and ERK2, suggesting nephrocystin recruits Pyk2 to cell-matrix adhesions.\",\n      \"method\": \"Immunoprecipitation, Western blot with phospho-specific antibody, ERK activation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of endogenous proteins plus functional phosphorylation readout at defined tyrosine residue, single lab\",\n      \"pmids\": [\"11493697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pyk2 tyrosine kinase activity is required for pulmonary vascular endothelial cell spreading, migration, morphogenesis, and pulmonary vein/artery angiogenesis ex vivo. Pyk2 kinase activity is required for expression of focal adhesion kinase, p130Crk-associated substrate, and HEF1, linking Pyk2 to focal adhesion formation and cytoskeletal reorganization.\",\n      \"method\": \"Adenovirus-mediated expression of Pyk2 mutants (kinase-dead), endothelial migration/morphogenesis assays, ex vivo angiogenesis assay, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-dead mutant with multiple functional readouts, single lab\",\n      \"pmids\": [\"11739395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RAFTK/Pyk2 is co-immunoprecipitated with PI3K upon platelet activation, and thrombin, ADP, and collagen induce phosphorylation of both PI3K and RAFTK. At low thrombin doses, RAFTK phosphorylation and platelet aggregation are PI3K activity-dependent. SHP-2 (protein tyrosine phosphatase-2) associates with RAFTK upon platelet activation in a PI3K-dependent manner.\",\n      \"method\": \"Immunoprecipitation, kinase assay, pharmacological inhibitors (wortmannin), Western blot\",\n      \"journal\": \"British journal of haematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of endogenous proteins plus pharmacological epistasis, single lab\",\n      \"pmids\": [\"11472358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HRG stimulation of T47D breast cancer cells induces RAFTK association with p190 RhoGAP, RasGAP, and ErbB-2. RAFTK mediates Src-dependent tyrosine phosphorylation of p190, and mutation of the Src binding site (Y402) of RAFTK abolishes p190 phosphorylation. ErbB-2 association with RAFTK is indirect and mediated by Src. Wild-type RAFTK expression increases breast cancer cell invasion; kinase mutant RAFTK-R457 and Y402 mutant do not.\",\n      \"method\": \"Immunoprecipitation, site-directed mutagenesis, invasion assay, Western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of key residue plus Co-IP and functional invasion assay, single lab\",\n      \"pmids\": [\"10713673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pyk2 interacts with ARA55 (androgen receptor coregulator) and phosphorylates ARA55 at tyrosine 43, impairing ARA55 coactivator activity and/or sequestering ARA55 to reduce AR transactivation. This indirect modulation of androgen receptor function by Pyk2 was demonstrated by yeast two-hybrid, co-IP, and in vitro phosphorylation.\",\n      \"method\": \"Yeast two-hybrid, Co-immunoprecipitation, in vitro phosphorylation, transactivation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro phosphorylation with site identification plus Co-IP, single lab\",\n      \"pmids\": [\"11856738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pyk2/RAFTK-mediated alpha-synuclein tyrosine phosphorylation at Y125 occurs in response to hyperosmotic stress, with Src-family kinases acting downstream of Pyk2 as the proximal kinases for alpha-synuclein. Dominant-negative Pyk2 reduces osmotic stress-induced alpha-synuclein phosphorylation.\",\n      \"method\": \"Western blot, dominant-negative Pyk2 construct, phospho-specific detection, site-directed mutagenesis of alpha-synuclein\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis with site-specific phosphorylation readout, single lab\",\n      \"pmids\": [\"12096713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In neonatal rat cardiomyocytes, adenoviral RAFTK/Pyk2 expression induces apoptosis via concurrent phosphorylation of Src, JNK, and p38, leading to PARP cleavage, caspase-3 activation, and DNA laddering. Mutation of the Y402 Src-binding site reduces DNA laddering. Wild-type or phosphorylation-deficient paxillin (mutated at Y31/Y118) prevents RAFTK-mediated apoptosis and preserves myofibril organization.\",\n      \"method\": \"Adenoviral expression, site-directed mutagenesis (Y402), caspase assay, PARP cleavage, paxillin rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of key Src-binding site plus multiple downstream apoptosis readouts and paxillin rescue, single lab\",\n      \"pmids\": [\"15322113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pyk2 acts as a scaffold for Src-dependent phosphorylation of PDK1 on Tyr9, enabling subsequent Src phosphorylation of PDK1 on Tyr373 and Tyr376 downstream of angiotensin II in vascular smooth muscle cells. Pyk2 and tyrosine-phosphorylated PDK1 co-localize in focal adhesions after Ang II stimulation. A Tyr9 mutant of PDK1 inhibits Ang II-induced paxillin phosphorylation and focal adhesion formation.\",\n      \"method\": \"Adenoviral expression, site-directed mutagenesis of PDK1 (Y9), confocal co-localization, immunoprecipitation, Western blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with defined phospho-site, co-localization, and functional adhesion readout, single lab\",\n      \"pmids\": [\"14585963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RAFTK/Pyk2 autophosphorylation occurs via a trans-acting (intermolecular) mechanism, not a cis-acting mechanism. Kinase-mutated RAFTK inhibits wild-type RAFTK autophosphorylation in a dose-dependent trans manner. Trans-autophosphorylation occurs only at Tyr402, and this is Src kinase activity-independent. Src significantly enhances RAFTK-mediated paxillin phosphorylation downstream of Tyr402. RAFTK self-associates, and this association is not dependent on a single domain.\",\n      \"method\": \"Dual-tag RAFTK constructs, immunoprecipitation, affinity chromatography, in vitro kinase assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with dual-tag co-expression, affinity chromatography, and Src independence established by SYF cells, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"15166227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"VEGF-induced p38 MAPK activation in endothelial cells is dependent on RAFTK/Pyk2 (dominant-negative Pyk2 reduces p38 activation) and is calcium-dependent (EGTA blocks it). Src family kinase activity is also required upstream of p38, and both Src and RAFTK/Pyk2 are essential for VEGF-induced endothelial cell migration. This pathway is distinct from PLC-dependent ERK activation.\",\n      \"method\": \"Dominant-negative Pyk2 expression, pharmacological inhibitors, kinase assay, migration assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative epistasis with defined pathway bifurcation, single lab\",\n      \"pmids\": [\"14676843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pyk2 autophosphorylation is necessary but not sufficient for glioma cell migration. The N-terminal domain of Pyk2 is required to stimulate migration (N-terminal deletion abolishes migration stimulation; autonomous N-terminal domain inhibits migration). Substitution of the Pyk2 C-terminal domain with the FAK C-terminal domain retains Pyk2-mediated migration stimulation, while substitution of the N-terminal domain with FAK N-terminus inhibits migration. siRNA silencing of Pyk2 inhibits glioma migration; re-expression of Pyk2 (but not FAK) restores it.\",\n      \"method\": \"Domain-swap chimeric constructs, siRNA knockdown, cell migration assay, RNA interference rescue\",\n      \"journal\": \"Neoplasia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-mapping with chimeras plus siRNA knockdown/rescue, single lab\",\n      \"pmids\": [\"15967096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Loss of VE-cadherin function triggers Rac1 activation and ROS production, which activate Pyk2. Active Pyk2 is recruited to cell-cell junctions and phosphorylates VE-cadherin-associated beta-catenin on tyrosine. Expression of dominant-negative CRNK (N-terminal deletion mutant) abolishes the increase in beta-catenin tyrosine phosphorylation and prevents loss of endothelial cell-cell contact.\",\n      \"method\": \"Dominant-negative CRNK expression, phospho-specific Western blot, immunofluorescence, electrical resistance measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative with functional endothelial barrier readout and substrate phosphorylation, single lab\",\n      \"pmids\": [\"15778498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SAPAP3 (SAP90/PSD-95-Associated Protein-3) interacts with FAK (residues 676-840) and PYK2 in yeast two-hybrid and GST pull-down assays. The three proteins co-distribute with PSD-95 and Src in postsynaptic density sucrose gradient fractions, suggesting SAPAP3 anchors PYK2 in postsynaptic densities.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, sucrose gradient fractionation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — yeast two-hybrid plus GST pull-down with biochemical fractionation, single lab\",\n      \"pmids\": [\"16202977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PCDH-gamma (gamma-protocadherins) binds PYK2 and FAK, and this interaction inhibits kinase activity. PYK2 activity is abnormally upregulated in Pcdh-gamma-deficient neurons. Overexpression of PYK2 induces apoptosis in chicken spinal cord. PCDH-alpha also interacts with PYK2 and FAK despite a distinct cytoplasmic domain; in neural tissue, PCDH-gamma and PCDH-alpha form complexes with PYK2 and/or FAK.\",\n      \"method\": \"Co-immunoprecipitation, kinase assay in Pcdh-gamma-null neurons, overexpression in chick spinal cord\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with kinase activity measurement in knockout neurons plus gain-of-function, single lab\",\n      \"pmids\": [\"19047047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pyk2 phosphorylates and activates PDZ-RhoGEF in vitro. Knockdown of PDZ-RhoGEF reduces RhoA activation by constitutively active Pyk2, placing PDZ-RhoGEF downstream of Pyk2. Knockdown of PYK2 or PDZ-RhoGEF markedly decreases RhoA activation by calcium ionophore A23187, establishing a PYK2/PDZ-RhoGEF/RhoA axis linking Ca2+ signaling to RhoA activation in vascular smooth muscle cells.\",\n      \"method\": \"In vitro phosphorylation/activation assay, adenoviral knockdown, RhoA translocation assay, Western blot\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro phosphorylation plus genetic knockdown epistasis, single lab\",\n      \"pmids\": [\"19759375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PYK2 interacts with MyD88 via MyD88's death domain (in vitro and in macrophages). PYK2-deficient macrophages exhibit reduced IκB phosphorylation/degradation, decreased NF-κB activation, and decreased IL-1β expression in response to LPS, placing PYK2 in the LPS-MyD88-NF-κB signaling pathway.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping (death domain), Western blot in PYK2-deficient macrophages\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain identification plus loss-of-function in macrophages with defined NF-κB readout, single lab\",\n      \"pmids\": [\"19955209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PSD-95 overexpression in PC6-3 cells induces trans-autophosphorylation of Pyk2 at Tyr402. In neurons, Ca2+ influx through NMDA receptors causes postsynaptic clustering and autophosphorylation of endogenous Pyk2 via Ca2+- and calmodulin-stimulated binding to PSD-95. This Pyk2 activation mechanism is critical for long-term potentiation in hippocampal CA1.\",\n      \"method\": \"Overexpression, in vitro oligomerization (antibody-induced), calcium imaging, LTP electrophysiology, immunofluorescence in neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro trans-autophosphorylation assay plus LTP physiology and endogenous protein localization, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"20071509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Pyk2 interacts with mGluR1 and mGluR5, precipitated from rat brain. Pyk2 associates with the second intracellular loop and distal C-terminal tail of mGluR1a (GST pull-down). Pyk2 overexpression attenuates agonist-stimulated inositol phosphate formation by displacing Galphaq/11 from the receptor. Pyk2 activity (calmodulin-, Src-, and PKC-dependent) is required for mGluR-stimulated ERK1/2 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation from rat brain, GST pull-down, IP formation assay, dominant-negative Pyk2, ERK assay\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — brain Co-IP plus GST pull-down domain mapping and functional rescue, single lab\",\n      \"pmids\": [\"20180987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STEP (striatal-enriched protein-tyrosine phosphatase) binds to Pyk2 and dephosphorylates it at Tyr402. STEP KO mice show enhanced phosphorylation of Pyk2 at Tyr402 and of its substrates paxillin and ASAP1. STEP opposes Pyk2 activation after KCl depolarization and blocks Pyk2 translocation to postsynaptic densities.\",\n      \"method\": \"Co-immunoprecipitation, phosphatase assay, Western blot in STEP KO mice, biochemical fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro phosphatase assay identifying Pyk2 as STEP substrate plus KO mouse validation with multiple readouts, single lab with multiple methods\",\n      \"pmids\": [\"22544749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FAK and PYK2 phosphorylate GSK3β at Y216, promoting β-catenin accumulation and Wnt/β-catenin pathway activation, and intestinal tumorigenesis in APCmin/+ mice. Phosphorylation of GSK3β(Y216) acts as a molecular determinant for GSK3β recruitment of β-TrCP. Pharmacological FAK/PYK2 inhibition suppresses adenoma formation in APCmin/+ mice with reduced phospho-GSK3β(Y216) and β-catenin.\",\n      \"method\": \"In vitro kinase assay, mutagenesis, APCmin/+ mouse model, pharmacological inhibition\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay establishing GSK3β(Y216) as substrate, with in vivo genetic and pharmacological validation in mouse tumor model\",\n      \"pmids\": [\"26274564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EGF induces rapid phosphorylation of PYK2 and its translocation to early endosomes where it co-localizes with EGFR and sustains downstream signals. PYK2 enhances EGF-induced STAT3 phosphorylation, while phospho-STAT3 directly binds to the PYK2 promoter to regulate PYK2 transcription. PYK2 and STAT3 also enhance c-Met expression, while c-Met augments their phosphorylation, forming a positive feedback loop.\",\n      \"method\": \"Immunofluorescence/confocal microscopy for co-localization with endosomes, ChIP for STAT3 binding to PYK2 promoter, Western blot, siRNA knockdown\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct endosomal co-localization with functional consequence plus ChIP, single lab\",\n      \"pmids\": [\"25648557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pyk2 is required for astrocyte migration after brain lesion. Pyk2-/- astrocytes migrated slower in in vitro wound healing and had delayed actin re-polymerization after latrunculin B treatment. Gelsolin was less enriched at the leading edge of migrating Pyk2-/- astrocytes, suggesting its lack of recruitment partially mediates the migration defect. TNFα-induced Pyk2 phosphorylation at Tyr402 increased PKC activity upstream.\",\n      \"method\": \"Pyk2 knockout mice, in vivo stab lesion, in vitro wound healing, actin dynamics assay, immunofluorescence\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with multiple localization and functional readouts in vivo and in vitro, single lab\",\n      \"pmids\": [\"26663135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Pyk2 co-localizes with cortactin at invadopodia and mediates EGF-induced cortactin tyrosine phosphorylation directly and indirectly via Src-mediated Arg kinase activation. This leads to actin polymerization in invadopodia, ECM degradation, and tumor cell invasion. siRNA knockdown and rescue experiments established Pyk2 as regulator of invadopodium-mediated functions, distinct from FAK which regulates focal adhesion-mediated motility.\",\n      \"method\": \"Protein array screening, Co-immunoprecipitation, siRNA knockdown, in vitro kinase assay, confocal microscopy, invasion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — protein array identification of cortactin as novel substrate plus in vitro kinase validation, Co-IP, localization, and functional rescue with multiple orthogonal methods\",\n      \"pmids\": [\"29133485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pyk2 is a direct tyrosine kinase of tau protein, phosphorylating tau in vitro and in vivo. Pyk2 colocalizes, interacts with, and phosphorylates tau. Pyk2 activity is increased in FynCA (constitutively active Fyn) mice and decreased in FynKO mice, placing Pyk2 downstream of Fyn in a tau phosphorylation cascade.\",\n      \"method\": \"In vitro kinase assay, Co-immunoprecipitation, transgenic mouse models (Pyk2/tau double transgenic, FynCA, FynKO), Western blot with phospho-tau antibodies\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay establishing tau as Pyk2 substrate plus in vivo genetic epistasis with Fyn, single lab\",\n      \"pmids\": [\"29782321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Alpha-protocadherins (Pcdha) regulate cortical neuron migration through the WAVE complex, and Pyk2 overexpression impairs cortical neuron migration via inactivation of the small GTPase Rac1, defining a molecular Pcdhα/WAVE/Pyk2/Rac1 axis in actin cytoskeletal dynamics.\",\n      \"method\": \"Pcdha cluster knockout mice, Pyk2 overexpression, Rac1 activity assay, cortical neuron migration assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined pathway placement (Rac1 assay) and functional migration readout, single lab\",\n      \"pmids\": [\"29911975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PYK2 positively regulates TAZ (and YAP) transcriptional activity in triple-negative breast cancer. PYK2 inhibition or knockdown facilitates proteasomal degradation of TAZ; this is specific to PYK2 and not observed with FAK inhibition. PYK2 enhances tyrosine phosphorylation of both TAZ and LATS1/2, promoting TAZ stability.\",\n      \"method\": \"siRNA knockdown, kinase inhibitor, Western blot, proteasomal degradation assay, transcriptional reporter\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown plus kinase inhibitor with proteasomal degradation and phosphorylation readouts, FAK-specificity control, single lab\",\n      \"pmids\": [\"30250159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Pyk2 interacts with the RhoGAP protein Graf1c in brain tissue (biochemical isolation), and Pyk2 kinase activity inhibits Graf1c, thereby activating RhoA. Aβ oligomer-induced reductions in dendritic spine motility and chronic spine loss require both Pyk2 kinase activity and RhoA activation, establishing a Pyk2/Graf1/RhoA pathway in synapse maintenance.\",\n      \"method\": \"Biochemical isolation of Pyk2-interacting proteins from brain, Co-immunoprecipitation, kinase assay, dendritic spine imaging, RhoA activity assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — brain biochemical isolation with functional validation in neurons and RhoA epistasis, single lab\",\n      \"pmids\": [\"30626696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD56 (NCAM) on NK cells is functionally linked to Pyk2: CD56-knockout NK92 cells show decreased Pyk2 Tyr402 phosphorylation, impaired lytic granule exocytosis, and impaired immunological synapse polarization. Cytotoxicity, exocytosis, and Pyk2 Tyr402 phosphorylation are all rescued by CD56 re-introduction.\",\n      \"method\": \"CRISPR/Cas9 knockout of CD56, rescue re-expression, Western blot (phospho-Y402), cytotoxicity assay, granule exocytosis assay, immunological synapse imaging\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean CRISPR KO with rescue, multiple orthogonal functional readouts establishing CD56-Pyk2-exocytosis axis, single lab\",\n      \"pmids\": [\"32510326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pyk2 phosphorylates Cx43 (connexin 43) at residues Y247, Y265, Y267, and Y313 (identified by mass spectrometry). Pyk2 can be activated by Src and active Pyk2 interacts with Cx43 at the plasma membrane. Overexpression of Pyk2 increases Cx43 phosphorylation; knockdown decreases it. PMA-induced Pyk2 activation decreases Cx43 gap junction intercellular communication (GJIC), and Pyk2 inhibition partially restores GJIC.\",\n      \"method\": \"In vitro phosphorylation screen, mass spectrometry, Western blot, immunofluorescence, dye transfer GJIC assay in HeLaCx43 cells and NRVMs\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation with MS identification of specific residues plus functional GJIC assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32956670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PKM2 promotes Pyk2 activation in macrophages downstream of TLR4, TLR7, and TLR9 pathways. Overexpression of PKM2 promotes TLR-induced Pyk2 activation, while PKM2 inhibition reduces it; co-immunoprecipitation showed PKM2-Pyk2 interaction. Pyk2 inhibitor phenocopied PKM2 inhibition in TLR pathway suppression.\",\n      \"method\": \"Co-immunoprecipitation, overexpression, siRNA, pharmacological inhibitor (Pyk2 inhibitor), Western blot, cytokine assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP with pharmacological epistasis, single lab, abstract does not detail mechanistic depth\",\n      \"pmids\": [\"34025679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PYK2 directly phosphorylates IRF5 (demonstrated by kinase inhibitor library screening and PYK2-deficient macrophage experiments). PYK2-deficient macrophages display impaired IRF5 activation and reduced inflammatory gene expression. The PYK2 inhibitor defactinib induces a transcriptomic signature similar to IRF5 deficiency and reduces pro-inflammatory cytokines in human colon biopsies and mouse colitis.\",\n      \"method\": \"Kinase inhibitor library screen, PYK2-deficient macrophages, transcriptomics, ex vivo human colon biopsy, mouse colitis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase screen plus genetic KO and pharmacological validation with in vivo and ex vivo disease models, single lab\",\n      \"pmids\": [\"34795257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PYK2 senses calcium through its kinase-FAT linker (KFL), which is disordered and contains an unusual calmodulin (CaM) binding element. KFL engages CaM through an ensemble of transient interactions, and calcium increases the association by promoting structural changes in CaM exposing auxiliary interaction sites. KFL forms fuzzy dimers that are enhanced by CaM binding. As a monomer, KFL associates with the PYK2 FERM-kinase fragment. CaM-induced dimerization promotes trans-autophosphorylation-based PYK2 activation.\",\n      \"method\": \"NMR spectroscopy, biophysical binding assays, structural analysis, mutagenesis\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional validation of CaM binding and dimerization mechanism, multiple biophysical methods, single lab\",\n      \"pmids\": [\"35945264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SIRPα forms a direct interaction with PTK2B/PYK2 through SIRPα's intracellular C-terminal domain, inhibiting PTK2B activation in macrophages. Necroptosis inhibition from SIRPα deficiency requires PTK2B activity, establishing PTK2B as a downstream effector of SIRPα signaling in macrophage homeostasis.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, PTK2B activity assay, SIRPα-/- macrophages, necroptosis assay\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain identification plus genetic KO and functional necroptosis readout, single lab\",\n      \"pmids\": [\"36202053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Pyk2 deletion in PS19 tauopathy mice exacerbates tau phosphorylation, tau accumulation, synapse loss, gliosis, and spatial memory impairment. Endogenous Pyk2 suppresses LKB1 and p38 MAPK activity, providing a mechanism by which Pyk2 loss leads to increased tau pathology. Thus, in tauopathy, endogenous Pyk2 suppresses rather than promotes tau phosphorylation.\",\n      \"method\": \"Pyk2 conditional knockout in PS19 mice, proteomic profiling, phospho-tau Western blot, LKB1/p38 activity assays, behavioral testing\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in defined tauopathy model with proteomic pathway identification, single lab\",\n      \"pmids\": [\"35501917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PTK2B directly phosphorylates TBK1 at Tyr591, increasing TBK1 oligomerization and activation. PTK2B also interacts with STING and promotes its oligomerization in a kinase-independent manner. PTK2B depletion reduces antiviral signaling in fibroblasts, macrophages, and dendritic cells, and Ptk2b-deficient mice are more susceptible to viral infection.\",\n      \"method\": \"In vitro kinase assay, Co-immunoprecipitation, Ptk2b-/- mice, viral infection assay, oligomerization assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay identifying TBK1 Y591 phosphorylation plus genetic KO mice with viral susceptibility and mechanistic oligomerization data, multiple orthogonal methods\",\n      \"pmids\": [\"37989995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mettl3/Ythdf2 regulate macrophage inflammation and ROS generation through Pyk2 mRNA stability. Mettl3 and Ythdf2 depletion increased Pyk2 mRNA stability and expression; RIP-PCR showed Ythdf2 directly targets Pyk2 mRNA in a Mettl3-dependent manner. Upregulated inflammatory signaling in Mettl3-knockdown cells was rescued by Pyk2 inhibitor, placing Pyk2 downstream of the Mettl3/Ythdf2 m6A axis.\",\n      \"method\": \"RNA-seq, RIP-PCR, siRNA knockdown, mRNA stability assay, pharmacological Pyk2 inhibition\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP-PCR establishing direct Ythdf2-Pyk2 mRNA interaction plus functional rescue with Pyk2 inhibitor, single lab\",\n      \"pmids\": [\"37952687\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTK2B/PYK2 is a calcium-sensitive, non-receptor tyrosine kinase of the FAK family that is activated by increases in intracellular Ca2+ through a calmodulin-binding disordered linker that promotes trans-autophosphorylation at Tyr402; once activated, it recruits and activates Src-family kinases (which further enhance PYK2 activity and phosphorylate downstream substrates), and functions as a signaling scaffold linking diverse extracellular stimuli (G protein-coupled receptors, integrins, growth factors, stress signals, NMDA receptors) to downstream pathways including JNK, ERK/Ras, p38 MAPK, NF-κB (via MyD88), RhoA (via PDZ-RhoGEF), Wnt/β-catenin (via GSK3β-Y216 phosphorylation), and antiviral innate immunity (via TBK1-Y591 phosphorylation and STING oligomerization), with its activity negatively regulated by STEP phosphatase (which dephosphorylates Tyr402), FIP200 (which binds the kinase domain), protocadherins, and SIRPα, and positively regulated by PSD-95-mediated clustering at postsynaptic densities and by nephrocystin recruitment to cell-matrix adhesions.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PTK2B (PYK2/RAFTK/CADTK) is a calcium-sensitive, non-receptor tyrosine kinase of the FAK family that couples diverse extracellular stimuli to cytoskeletal remodeling, MAP kinase cascades, and immune signaling [#0, #1, #2]. Its activation is gated by intracellular Ca2+: the disordered kinase-FAT linker contains a calmodulin-binding element whose Ca2+-promoted engagement of CaM drives fuzzy dimerization and intermolecular (trans) autophosphorylation specifically at Tyr402, a step that is Src-independent but creates the Src-binding site that amplifies downstream substrate phosphorylation [#23, #46]. Once activated, PYK2 nucleates signaling complexes by recruiting Src-family kinases, Grb2, and paxillin through its phospho-Tyr and proline-rich/C-terminal domains [#1, #4, #7], and functions both as a kinase and as a scaffold linking integrin, GPCR, growth factor, and stress inputs to JNK, ERK/Ras, and p38 MAPK pathways [#2, #5, #8, #24]. PYK2 directly phosphorylates a broad substrate range—the Kv1.2 potassium channel, GSK3\\u03b2 at Tyr216 to activate Wnt/\\u03b2-catenin signaling and intestinal tumorigenesis, cortactin at invadopodia to promote ECM degradation and invasion, connexin-43 to suppress gap-junction communication, and the antiviral kinase TBK1 at Tyr591 to drive its oligomerization and innate immune signaling [#7, #34, #37, #43, #49]. It activates the small GTPase RhoA via PDZ-RhoGEF and Graf1, linking Ca2+ to actin dynamics and synapse maintenance [#29, #41], and operates in macrophage inflammatory signaling through MyD88 and IRF5 [#30, #45]. PYK2 activity is negatively regulated by the phosphatase STEP, which dephosphorylates Tyr402, by FIP200 binding the kinase domain, and by protocadherins and SIRP\\u03b1, and is positively organized by PSD-95-mediated postsynaptic clustering downstream of NMDA-receptor Ca2+ influx, where it is required for hippocampal LTP [#12, #31, #33, #28, #47]. In the brain it phosphorylates tau and contributes to synaptic and tauopathy phenotypes [#38, #48]. Beyond kinase signaling, PYK2 controls cell migration, spreading, apoptosis, and cell-cycle progression in a manner distinct from FAK and mapped to its N- and C-terminal domains [#13, #14, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that a FAK-related cytoplasmic tyrosine kinase exists outside focal-adhesion receptors answered whether non-integrin stimuli could engage a FAK-like kinase, defining PYK2 as a distinct cytoplasmic enzyme.\",\n      \"evidence\": \"cDNA cloning and sequence analysis with thrombin-induced phosphorylation in megakaryocytic cells\",\n      \"pmids\": [\"7499242\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural basis for activation defined\", \"Substrates and downstream pathways unidentified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showing intrinsic kinase/autokinase activity, fibronectin-induced focal-adhesion localization, and SH2-mediated recruitment of Src, Fyn, and Grb2 established PYK2 as an integrin-responsive scaffold that recruits Src-family kinases.\",\n      \"evidence\": \"In vitro kinase assay, reciprocal Co-IP, and confocal localization in megakaryocytic and COS cells\",\n      \"pmids\": [\"8695788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Autophosphorylation site not defined\", \"Direct substrates not identified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placing PYK2 upstream of JNK in response to TNF-alpha, UV, and osmotic shock connected the kinase to stress-activated signaling, extending its role beyond adhesion.\",\n      \"evidence\": \"Overexpression and dominant-negative epistasis with JNK activity readout\",\n      \"pmids\": [\"8670418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intermediate signaling components to JNK not resolved\", \"Direct vs scaffold contribution unclear\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying Ca2+/PKC-dependent, calpain-regulated activation in platelets and TCR-stimulated T cells answered how surface-receptor signals feed into PYK2, linking it to calcium and cytoskeletal integrity across cell types.\",\n      \"evidence\": \"Platelet and T-cell activation assays, pharmacological dissection, SH2-domain binding and Co-IP\",\n      \"pmids\": [\"9099753\", \"9091579\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular Ca2+ sensor not yet defined\", \"Functional consequences of partner recruitment incomplete\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating GPCR-coupled activation (muscarinic, CCR5, angiotensin II) with substrate phosphorylation of Kv1.2 and downstream Ras/ERK, JNK and p38 established PYK2 as a hub bridging GPCR signaling to ion channels and MAPK cascades.\",\n      \"evidence\": \"Stable cell lines, site-directed mutagenesis of phospho-tyrosines, in vitro phosphorylation, dominant-negative epistasis, Ras-GTP/ERK assays\",\n      \"pmids\": [\"9560226\", \"9446638\", \"9774361\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct receptor-PYK2 coupling mechanism not defined\", \"Generality of Kv1.2 phosphorylation in vivo untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Linking PYK2 kinase activity to dexamethasone-induced apoptosis in myeloma cells assigned the kinase a pro-apoptotic role in a defined, stimulus-specific death pathway.\",\n      \"evidence\": \"Transient overexpression and kinase-inactive mutant in apoptosis assays\",\n      \"pmids\": [\"10597281\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apoptotic effector mechanism downstream of PYK2 not defined\", \"Cell-type generality unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying FIP200 as a direct kinase-domain inhibitor that dissociates upon stimulation provided the first negative-regulatory mechanism for PYK2.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding and kinase-inhibition assays, Co-IP in SYF cells\",\n      \"pmids\": [\"10769033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of FIP200-mediated inhibition not resolved\", \"Stimulus-induced dissociation trigger unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defining domain-specific control of migration, spreading, cell-cycle, and neurite outgrowth—distinct from FAK and mapped to N- and C-terminal domains—established PYK2's non-redundant cellular roles.\",\n      \"evidence\": \"Chimeric/domain-deletion constructs, dominant-negative CRNK, motility and flow-cytometry assays in monocytes, PC12, and fibroblasts\",\n      \"pmids\": [\"10980697\", \"10934044\", \"11062241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effectors mediating C-terminal cell-cycle inhibition not identified\", \"Mechanism of cytoplasmic vs focal-adhesion localization difference unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying nephrocystin-mediated recruitment to cell-matrix adhesions and PI3K/SHP-2 association in platelets clarified how PYK2 is positioned at adhesion complexes and its Tyr402 activation triggered.\",\n      \"evidence\": \"Co-IP of endogenous complexes, phospho-Y402 Western blot, pharmacological PI3K epistasis, ERK and angiogenesis assays\",\n      \"pmids\": [\"11493697\", \"11472358\", \"11739395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect nature of partner interactions not fully resolved\", \"In vivo relevance of complexes untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing PYK2 as a Src-coordinating scaffold phosphorylating p190RhoGAP, PDK1, ARA55, and alpha-synuclein, and as a driver of breast-cancer invasion and cardiomyocyte apoptosis, broadened its substrate repertoire and showed Tyr402 is required for these outputs.\",\n      \"evidence\": \"Site-directed mutagenesis (Y402, PDK1-Y9), Co-IP, in vitro phosphorylation, invasion and apoptosis assays\",\n      \"pmids\": [\"10713673\", \"11856738\", \"12096713\", \"15322113\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs Src-relayed phosphorylation of each substrate not always separated\", \"Physiological substrate set incomplete\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating PYK2 scaffolds Src-dependent PDK1 phosphorylation at focal adhesions integrated PYK2 into adhesion-coupled signaling downstream of angiotensin II.\",\n      \"evidence\": \"Adenoviral expression, PDK1-Y9 mutagenesis, confocal co-localization, Co-IP in vascular smooth muscle\",\n      \"pmids\": [\"14585963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream PDK1 effector outputs not mapped\", \"Generality beyond VSMC unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that autophosphorylation occurs in trans, only at Tyr402, and is Src-independent answered the long-standing mechanism of PYK2 activation and defined the order: trans-autophosphorylation precedes Src recruitment and substrate amplification.\",\n      \"evidence\": \"Dual-tag constructs, affinity chromatography, in vitro kinase assays in SYF cells, plus VEGF-dependent Ca2+-sensitive p38 pathway dissection\",\n      \"pmids\": [\"15166227\", \"14676843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural trigger for self-association not yet defined\", \"Stoichiometry of active dimers unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping migration stimulation to the N-terminal domain and establishing junctional recruitment with beta-catenin phosphorylation and SAPAP3/PSD-95 anchoring connected PYK2 to barrier function, glioma migration, and postsynaptic positioning.\",\n      \"evidence\": \"Domain-swap chimeras, siRNA knockdown/rescue, dominant-negative CRNK, junctional imaging, yeast two-hybrid and PSD fractionation\",\n      \"pmids\": [\"15967096\", \"15778498\", \"16202977\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"N-terminal effectors driving migration unidentified\", \"Direct vs scaffold role at junctions not fully separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing protocadherin binding inhibits PYK2 and that PYK2 is hyperactive in Pcdh-deficient neurons added a developmental, neuron-specific layer of negative regulation.\",\n      \"evidence\": \"Co-IP, kinase assays in Pcdh-gamma-null neurons, overexpression in chick spinal cord\",\n      \"pmids\": [\"19047047\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of protocadherin-mediated inhibition unknown\", \"Direct vs complex-mediated effect not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining the PYK2/PDZ-RhoGEF/RhoA axis and the MyD88 interaction established how PYK2 converts Ca2+ signals to RhoA activation and links it to innate NF-\\u03baB inflammatory signaling.\",\n      \"evidence\": \"In vitro phosphorylation/activation, knockdown epistasis, RhoA assays, Co-IP with death-domain mapping in macrophages\",\n      \"pmids\": [\"19759375\", \"19955209\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PYK2-MyD88 phosphorylation event not defined\", \"PDZ-RhoGEF phospho-site not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating PSD-95-driven postsynaptic clustering and Ca2+/CaM-dependent Tyr402 autophosphorylation required for hippocampal LTP, plus mGluR scaffolding, established PYK2 as a key effector of NMDA-receptor calcium signaling in synaptic plasticity.\",\n      \"evidence\": \"Overexpression, in vitro oligomerization, calcium imaging, LTP electrophysiology, brain Co-IP and GST pull-down\",\n      \"pmids\": [\"20071509\", \"20180987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Synaptic substrates mediating LTP not fully defined\", \"Quantitative link between clustering and kinase output incomplete\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying STEP as a phosphatase that dephosphorylates Tyr402 and blocks postsynaptic translocation defined a key physiological off-switch opposing depolarization-induced PYK2 activation.\",\n      \"evidence\": \"In vitro phosphatase assay, Co-IP, STEP KO mice with paxillin/ASAP1 substrate readouts and fractionation\",\n      \"pmids\": [\"22544749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of STEP-PYK2 engagement not defined\", \"Other phosphatases not excluded\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Establishing GSK3\\u03b2-Y216 as a direct substrate driving Wnt/\\u03b2-catenin signaling and intestinal tumorigenesis, plus EGFR-endosomal STAT3 feedback and astrocyte migration roles, connected PYK2 to oncogenic transcriptional programs and tissue repair.\",\n      \"evidence\": \"In vitro kinase assay, mutagenesis, APCmin/+ mouse model with pharmacological inhibition, ChIP, knockout astrocytes\",\n      \"pmids\": [\"26274564\", \"25648557\", \"26663135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of STAT3 feedback loop untested\", \"Gelsolin recruitment mechanism in astrocytes incomplete\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying cortactin as a direct invadopodial substrate distinguished PYK2 from FAK by assigning it control of invadopodium-mediated ECM degradation and invasion.\",\n      \"evidence\": \"Protein-array substrate screening, in vitro kinase assay, Co-IP, siRNA knockdown/rescue, invasion assays\",\n      \"pmids\": [\"29133485\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of direct vs Arg-mediated cortactin phosphorylation not quantified\", \"In vivo metastasis relevance untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placing PYK2 downstream of Fyn as a direct tau kinase and within a Pcdha/WAVE/Rac1 neuronal migration axis extended its substrate range into neurodegeneration-relevant and developmental pathways.\",\n      \"evidence\": \"In vitro kinase assays, Co-IP, FynCA/FynKO and Pcdha-cluster knockout mice, Rac1 activity and migration assays\",\n      \"pmids\": [\"29782321\", \"29911975\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tau phosphosites and pathological consequence in vivo not fully resolved at this stage\", \"Mechanism of Rac1 inactivation by PYK2 unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying PYK2 as a positive regulator of TAZ/YAP stability in triple-negative breast cancer assigned a FAK-independent role in Hippo-pathway transcriptional output.\",\n      \"evidence\": \"siRNA knockdown, kinase inhibitor with FAK-specificity control, proteasomal-degradation and reporter assays\",\n      \"pmids\": [\"30250159\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TAZ/LATS phosphosites not mapped\", \"In vivo tumor relevance untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defining a PYK2/Graf1/RhoA pathway required for amyloid-beta-induced spine loss linked PYK2 RhoGAP inhibition to synapse maintenance in neurodegeneration.\",\n      \"evidence\": \"Brain biochemical isolation, Co-IP, kinase assay, dendritic-spine imaging and RhoA activity assay\",\n      \"pmids\": [\"30626696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Graf1 phosphosite not identified\", \"Direct vs indirect inhibition of Graf1c unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapping connexin-43 phosphosites and the CD56-PYK2 axis in NK cells connected PYK2 to gap-junction communication and immune-synapse-driven cytotoxic granule exocytosis.\",\n      \"evidence\": \"In vitro phosphorylation with mass spectrometry, GJIC dye-transfer assays, CRISPR CD56 knockout/rescue with cytotoxicity and synapse imaging\",\n      \"pmids\": [\"32956670\", \"32510326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CD56 couples to PYK2 Tyr402 phosphorylation not defined\", \"Functional consequence of each Cx43 phosphosite not separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolving that the disordered kinase-FAT linker binds calmodulin and that Ca2+ promotes CaM-induced fuzzy dimerization driving trans-autophosphorylation provided the structural mechanism for calcium-sensing activation, unifying decades of Ca2+-dependence observations.\",\n      \"evidence\": \"NMR spectroscopy, biophysical binding assays, mutagenesis of the KFL/FERM-kinase fragment\",\n      \"pmids\": [\"35945264\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length activated complex structure not determined\", \"Quantitative coupling of dimer formation to cellular activity incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying SIRP\\u03b1 as a direct C-terminal inhibitor of PYK2 controlling macrophage necroptosis added a receptor-coupled negative-regulatory mechanism in myeloid homeostasis.\",\n      \"evidence\": \"Co-IP with domain mapping, PYK2 activity assay, SIRP\\u03b1-null macrophages, necroptosis assay\",\n      \"pmids\": [\"36202053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of inhibition not resolved\", \"Downstream necroptosis effector pathway from PYK2 incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showing Pyk2 deletion worsens tauopathy by relieving its suppression of LKB1/p38 reframed PYK2 as a context-dependent suppressor of tau pathology, in apparent contrast to its direct tau-kinase activity.\",\n      \"evidence\": \"Conditional Pyk2 knockout in PS19 mice, proteomics, phospho-tau Western blot, LKB1/p38 activity assays, behavior\",\n      \"pmids\": [\"35501917\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation of direct tau phosphorylation with net protective role unresolved\", \"Mechanism of LKB1/p38 suppression not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Establishing PYK2 as a direct TBK1-Y591 kinase that also drives STING oligomerization kinase-independently defined a non-redundant role in antiviral innate immunity, with knockout mice showing increased viral susceptibility.\",\n      \"evidence\": \"In vitro kinase assay, Co-IP, oligomerization assays, Ptk2b-/- mice and viral infection\",\n      \"pmids\": [\"37989995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of kinase-independent STING oligomerization unclear\", \"Upstream trigger for antiviral PYK2 activation not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining IRF5 as a direct PYK2 substrate and showing m6A/Mettl3/Ythdf2 control of Pyk2 mRNA stability connected the kinase to transcriptional control of macrophage inflammation and to post-transcriptional regulation of its own abundance.\",\n      \"evidence\": \"Kinase inhibitor library screen, PYK2-deficient macrophages, transcriptomics, colitis models, RIP-PCR and mRNA-stability assays\",\n      \"pmids\": [\"34795257\", \"37952687\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"IRF5 phosphosites not mapped\", \"Upstream signals controlling m6A-mediated Pyk2 regulation unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many context-dependent and even opposing outputs of PYK2 (pro- vs anti-tumorigenic, pro- vs anti-tau-pathology, kinase-dependent vs scaffold roles) are selected within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model of how stimulus identity dictates which PYK2 substrate/scaffold output dominates\", \"Full-length structures of activated PYK2 complexes lacking\", \"In vivo substrate hierarchy across tissues undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 7, 23, 34, 37, 43, 49]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [1, 23]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [46, 31]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 4, 7, 49]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13, 11]},\n      {\"term_id\": \"GO:0005925\", \"supporting_discovery_ids\": [1, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [35]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [26, 43]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [7, 8, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8, 24, 29, 34]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [30, 42, 45, 49]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [31, 32, 38, 41]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [34, 37, 40]}\n    ],\n    \"complexes\": [\"postsynaptic density\"],\n    \"partners\": [\"SRC\", \"FYN\", \"GRB2\", \"PXN\", \"FIP200\", \"PTPN5\", \"MYD88\", \"SIRPA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}